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ABSTRACT
THE EFFICACY OF PSYCHOSOCIAL SERVICES IN COMPREHENSIVE CANCER CARE:
A PROGRAM EVALUATION
Nicola B. Mucci
Antioch University Seattle
Seattle, WA
On average, regardless of other factors, persons affected by cancer will experience some level of
distress associated with the disease and its sequelae. Left untreated, psychosocial problems can,
and often do, adversely affect a person’s health and healthcare treatment. As a result, national
initiatives have been implemented to recognize and treat psychosocial stressors to optimize a
person’s functioning and facilitate successful movement through the medical system. A program
evaluation was conducted to examine how Providence Regional Cancer Partnership has
addressed the psychosocial needs of its patient population. Specifically, the psychosocial
services department, Patient Support Services, was evaluated to understand how program
services were (a) utilized and represented across patient demographics and (b) valued or
regarded within the larger cancer treatment center. Archival data was gathered from electronic
health records to determine how program services were utilized and by whom. Two surveys were
designed and distributed to understand the experiences and opinions of program services.
Evaluation findings clarified areas of strength and identified areas of improvement. Program
strengths provided insight into services that were well utilized and most valued and affirm the
program’s mission to reach a broad patient population and provide services to patients in high
need. Utilization of program services indicated two areas of underrepresentation (gender and
cancer diversity) and one area of underutilization (support groups). Areas of program
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dissatisfaction identified by patients and staff were categorized into three themes: education and
outreach; program services and access; and Patient Support Services staffing. Recommendations
were developed with input from Patient Support Services and presented to stakeholders and
program administrators to make informed decisions about desired program changes. In general,
evaluation findings provided efficacy of program services and support for the merit of
psychosocial services within a cancer treatment facility. The electronic version of this
dissertation is at AURA: Antioch University Repository and Archive, http://aura.antioch.edu/
and OhioLINK ETD Center, https://etd.ohiolink.edu
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Chapter I: Background
In 2015, the National Comprehensive Cancer Network ([NCCN], 2016b) estimated
1,658,370 new cancer cases, with approximately 36%, or 589,430 , cancer-related deaths in the
United States. Data available from the National Cancer Institute’s Surveillance Epidemiology
and End Results (SEER) predicts that, per all incidences of cancer, men have a 42% lifetime risk
of developing cancer while women have a 38% lifetime risk (American Cancer Society [ACS],
2016). Thus, nearly one half of all men and one third of all women in the United States will
develop cancer in their lifetime.
Fortunately, despite a high prevalence of cancer among all Americans, substantial
progress has been made in the field of oncology which has significantly extended the life
expectancy of persons with cancer, with many people achieving remission or living with cancer
as a chronic condition (ACS, 2016). Nevertheless, people with cancer face an array of physical,
psychological, social, and economic hardships often as a result of a cancer diagnosis and its
sequelae. And while advances in biomedical care have improved the early detection and
treatment of many malignant tumors, similar recognition has not been paid to the necessity of
high quality psychosocial care in addressing problems associated with cancer. Indeed, survivors
of cancer and family members have reported a lack of understanding and/or failure to address
important psychosocial needs by their cancer care providers (Institute of Medicine [IOM], 2008).
In response to these concerns, national initiatives have been implemented over the years to
recognize and treat psychosocial stressors to optimize the overall health of persons with cancer.
New standards of care emphasize the inclusion of psychosocial services in delivering high
quality cancer care because, as the sentiment of the World Health Organization expressed in
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2001, without mental health, good health cannot exist. Left untreated, psychosocial problems
can, and often do, adversely affect a person’s health and healthcare treatment in many ways.
This dissertation outlines psychosocial stressors that commonly accompany a cancer
diagnosis and the individual and systemic risks of not treating psychosocial concerns as an
integral part of cancer care. A program evaluation was conducted to examine how one
institution, Providence Regional Cancer Partnership, has addressed the psychosocial needs of its
patient population. An internal behavioral health team known as Patient Support Services
assesses distress, identifies psychosocial needs, and delivers a wide array of onsite program
services to help patients manage distress and effectively cope with the rigors of cancer and its
sequelae throughout all phases of the cancer continuum. A strength of the Cancer Partnership is
its ability to provide a robust program of onsite psychosocial services that reaches far beyond
distress screening required by governing oncology sanctions. This program evaluation sought to
determine the overall merit of Patient Support Services and provide feedback to improve
psychosocial program services as indicated by data on the utilization of services and patient and
staff feedback.
Psychosocial Distress Among Cancer Patients
While advances in early detection and treatment of cancer have improved overall survival
rates of patients with cancer, the effects of cancer and treatment often have long-lasting
consequences that can interfere with a person’s ability to function optimally, contributing to
psychological distress. Distress is an all-encompassing term chosen by the NCCN (2016b) to
describe the subjective experience of adversity and psychological hardship likely to accompany
cancer. The term “distress” aims to normalize psychological hardship, rather than pathologize
persons reacting to the wide-reaching affects of cancer. In 1999, the term was selected by an
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interdisciplinary group to reduce the potential barrier between people in need of psychosocial
services, but reluctant to label themselves as needing help, and the clinicians who provide
services. Distress was defined globally as
A multifactorial unpleasant emotional experience of a psychological (i.e, cognitive,
behavioral, emotional), social, and/or spiritual nature that may interfere with the ability to
cope effectively with cancer, its physical symptoms and its treatment. Distress extends
along a continuum, ranging from common normal feelings of vulnerability, sadness, and
fears to problems that can become disabling, such as depression, anxiety, panic, social
isolation, and existential and spiritual crisis. (NCCN, 2016b, p. DIS-2)
While the prevalence of psychosocial distress varies based on individual demographics
(i.e., age, gender, race, marital status, income) as well as type and stage of cancer, research
suggests that one third of patients newly diagnosed with first time or recurrent cancer will
experience a significant level of distress as they adapt to their diagnosis (Zabora,
Brintzenhofeszoc, Curbow, Hooker, & Piantadosi, 2001). Zabora and colleagues examined
psychological distress among 4,496 patients with cancer and found the overall prevalence rate of
distress was 35.1%. Of 14 cancer diagnoses included in the study, those cancers with poorer
prognostic rates and/or multi-modality treatments demonstrated greater rates of distress. Lung
cancer patients were found to have the highest prevalence of distress (43.4%) followed by
patients with brain, liver, pancreatic, and head and neck cancers, while gynecological cancer
patients showed lower prevalence rates (29.6%).
On average, regardless of other factors, persons affected by cancer will experience some
level of distress associated with their cancer diagnosis as well as the overall effects of the disease
and/or related treatments. Indeed, symptoms of psychological distress are expected and mild
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symptoms can be deemed an appropriate, “normal” response to enormity of the disease and
rigors of treatment. Helgseon and Cohen (1996, as cited in IOM, 2008) defined psychological
adjustment as an “adaption to disease without continued elevations of psychological distress (e.g,
anxiety, depression) and loss of role function (i.e., social, sexual, vocational)” (p. 54). Even with
the most robust resources available to a person, cancer will disrupt all aspects of a person’s daily
life including relationships, employment, and finances (Zabora et al., 2001). The most commonly
reported effects of cancer depict both physiological—fatigue and pain—and emotional– anxiety
and depression—symptoms as patients confront their illness and the numerous cancer-related
decisions that face them. Other symptoms of expected distress include feelings of uncertainty
and fear about the future or feeling out of control; anger, irritability, and grief as one’s health and
functioning changes; thoughts of morbidity and mortality; sleeplessness, changes in appetite and
concentration, concerns about the illness and a preoccupation with side effects from treatment;
and concerns about one’s identity and social roles (NCCN, 2016b). Most patients will experience
signs of distress during pivotal moments, for instance while facing a potential diagnosis of
cancer, throughout arduous phases of treatment, and following the completion of treatment.
While psychosocial distress is expected even among psychologically healthy persons,
persons with preexisting psychiatric disorders represent a more vulnerable population of cancer
patients who may have greater difficulty coping with the disease (NCCN, 2016b). Patients bring
with them a multitude of characteristics and psychosocial factors and, not surprisingly, those
variables can either add to patients’ resiliency— nearly two-thirds of patients successfully adapt
to their cancer diagnosis without clinical intervention— or hinder their ability to adapt to their
cancer experience, the remaining one third demonstrated by Zabora et al. (2001). Research
conducted as far back as the 1980s (Wesiman, Worden, & Sobel, 1980, as cited in Zabora et al.,

5
2001), demonstrated that preexisting psychosocial factors, including social support and previous
history of functioning, significantly contributed to a person’s initial adaption to cancer. With
psychosocial variables in mind, providers may begin to identify persons at risk of experiencing
greater difficulty and poor adjustment.
It is of the utmost importance to identify and treat the subset of patients likely to
experience clinically significant levels of distress to optimize patients’ successful movement
through the medical system. Compared to patients with mild symptoms of distress, persons
exhibiting symptoms of severe distress may show signs of excessive worry or fear; extreme
sadness, feelings of despair or hopelessness; confused or unclear thinking; and severe problems
involving their family, spirituality, or social concerns (NCCN, 2016b). Patients with a history of
psychiatric illness, including substance abuse and cognitive disorders, are at greater risk of
experiencing severe psychosocial distress. Other populations at risk of acute distress include
persons with complex comorbid disorders or difficult to control symptoms and persons with an
array of social issues such as limited social support, limited access to resources or fewer financial
resources, conflict with family members or caregivers, communication barriers or cultural and
spiritual/religious concerns. Patients may also be at greater risk of distress during periods of
vulnerability throughout the course of treatment. Vulnerable periods may include initial workup
prior to diagnosis, changes in treatment modalities, treatment resistance or failure, side effects or
complications during treatment, treatment completion, disease progression or recurrence, and
end of life (NCCN, 2016b). Clearly, many factors may complicate an already arduous experience
for persons facing cancer, including a history of psychiatric illness, psychosocial issues, and
treatment-related concerns or complications.
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Consequences of Unmet Psychosocial Needs
Given the high prevalence of distress among cancer patients and implications for coping
with the disease and rigors of treatment, the importance of addressing psychosocial distress
cannot be understated. Indeed, a failure to identify and treat clinically significant levels of
distress can have negative effects on an individual and organizational level. Many patients
experience significant mental health problems that can impair quality of life and the ability to
carry out social and functional roles. Ultimately, untreated psychosocial problems and distress
can affect the onset and progression of disease interfering with treatment compliance,
compromising treatment outcomes, and escalating healthcare costs (IOM, 2008).
Meta-analyses conducted by the National Comprehensive Cancer Network (2016b) and
Institute of Medicine (2008), two of the leading international organizations responsible for
creating oncology standards of care, have discussed the perils of unmet psychosocial needs and
the affects on patients. In general, research has focused on three psychosocial variables proven to
affect patient care and treatment outcomes: depression and mental health issues, inadequate
social support, and insufficient finances or access to resources.
Emotional distress. All persons are at risk of emotional suffering when confronted with
a potentially life-threating disease such as cancer (NCCN, 2016b). People afflicted by depression
or anxiety and comorbid health conditions tend to report more social and functional impairment
than their non-depressed, non-anxious peers. Somatic symptoms that accompany emotional
distress such as sleep issues, fatigue, and pain can exacerbate physical symptoms associated with
cancer and treatment, leading to further functional impairment and greater difficulty engaging in
change behaviors that promote health (IOM, 2008).

7
By and large, the most serious consequence of emotional distress on health is its
interference with adaptive coping and adherence to treatment recommendations. Studies have
indicated that as many as 20% of cancer patients have been noncompliant with treatment
recommendations including oral chemotherapy, radiation, and adjuvant hormone therapy (IOM,
2008). Psychological distress can alter patients’ perceptions and motivation to engage in healthy,
adaptive coping skills. Self-defeating and pessimistic attitudes, for example, may contribute to
feelings of helplessness and powerlessness that prevent patients from engaging in treatmentrelated decisions. Adaptive coping skills may be averted or delayed and patients may gravitate
towards unhealthy or avoidant behaviors—smoking, excessive alcohol use, medication misuse—
in an effort to cope with emotional distress. Avoidant-based coping, in particular, has harmful
consequences on treatment adherence as patients disengage from the problem-solving skills and
decision-making (IOM, 2008).
Depression and other psychological disorders can also impair cognition including thought
processes, perceptions, memory, and executive functioning skills (American Psychiatric
Association, 2013). Thus, stress, anxiety, and depression among cancer patients can affect the
ability to adequately process complicated information necessary to understand the disease and
treatment options. Distraught patients may struggle to work effectively with their treatment
providers or participate in making treatment decisions leading to poorer outcomes (IOM, 2008).
Inadequate social support. Social support plays a pivotal role in helping persons with
cancer manage their illness and shield them from the array of stressors involved. Social support
can improve healthcare outcomes by helping patients cope with the emotional stress of illness
and the rigors of treatment procedures, providing informational support during instrumental
treatment phases, and/or logistical support as a person’s functional abilities and roles change
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throughout the course of illness and treatment. With the knowledge that social support can help
mitigate the stressors related to the challenges of illness, it is not surprising that inadequate or
dysfunctional support systems can negatively affect the course of illness, including worse
treatment outcomes and higher mortality rates (IOM, 2008). Inadequate social relationships lead
to a decreased ability to cope with illness and often increase stress rather than insolate a person
from it.
Insufficient financial and material resources. Persons with fewer financial resources
are also at greater risk of developing severe distress. Limited access to resources or financial
means can interfere with a person’s ability to fully participate in healthcare, thereby inadequately
managing his/her illness. Indeed, a survey conducted in 2006 on households that were affected
by cancer found that 8% of families had delayed or declined treatment because of the cost of care
(IOM, 2008). Given the necessity of wealth and access to resources in this country, especially in
the management of disease and health maintenance, socioeconomic status has become a strong
predictor of illness, disability, and mortality rates (IOM, 2008).
In general, psychosocial stressors such as those described above—depression and mental
health problems, inadequate social support, and insufficient financial resources—are correlated
with higher morbidity and mortality rates as well as lower functional status (IOM, 2008). In and
of itself, psychological distress can cause emotional suffering and significantly decrease a
person’s effectiveness in his/her social and economic roles. Furthermore, psychosocial problems
can affect health by obstructing a person’s ability to effectively manage his/her illness, thereby
creating suboptimal conditions for treatment. Studies have shown that psychosocial problems can
impede access to necessary healthcare and treatment resources, interfere with treatment
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compliance, and restrict engagement in adaptive behaviors that promote good health (IOM,
2008).
In summary, persons with cancer must approach their cancer treatment from two angles:
First, they must face their illness and the risks to their physical health that are at stake. Secondly,
they must confront the many psychosocial challenges related to the sequelae of cancer that
threaten optimal functioning and high quality healthcare. As Zabora and colleagues indicated in
their 2001 review of the prevalence of psychological distress among cancer patients, “Failure to
detect and treat elevated levels of distress jeopardizes the outcomes of cancer therapies,
decreases patients’ quality of life and increases healthcare costs” (p. 27). Thus, the detection and
treatment of clinically significant levels of distress is critical in providing comprehensive cancer
treatment.
Early psychological intervention in particular, can benefit both patients and the medical
institution. While psychological interventions may not affect cancer cure rates, evidence supports
its efficacy helping patients adopt positive coping mechanisms that can minimize symptoms of
physical and psychological distress and improve overall health (IOM, 2008). In general, patients
who receive psychosocial services have better quality of living and a lower likelihood of
developing severe emotional disorders (NCCN, 2016b). Additionally, these patients report
greater satisfaction in their cancer care. Systemically, psychological interventions during
appropriate treatment intervals help patients optimize their healthcare experience; psychosocial
interventions are expected to improve treatment compliance and provider recommendations,
reduce unnecessary office visits with physicians and emergency room resources, and increase
communication and collaboration with providers (NCCN, 2016b). Further, psychosocial services
within oncology aim to benefit the community by promoting better health and wellness and
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working to improve the delivery of services and care for all persons affected by cancer
(Association of Oncology Social Work [AOSW], 2012).
Psychosocial Standards of Care and Distress Management
The National Comprehensive Cancer Network (2016a), an alliance of the world’s most
premier cancer centers, is collectively responsible for the development of standards and clinical
practice guidelines affecting patient care, research, and education. NCCN creates resources that
lead cancer institutions in delivering high quality cancer care, including the identification and
treatment of psychosocial services in patients with cancer. Indeed, since 1997, NCCN (2016b)
has sought to create provisions to advocate for and improve psychosocial care in oncology
settings. The first clinical practice guidelines on the management and treatment of distress were
published in 1999 by a panel of interdisciplinary specialists. Since its inception, these guidelines
have provided a framework for understanding psychosocial distress and they continue to inform
all future handbooks for oncology specialists and clinicians.
In 2008, the Institute of Medicine issued the first report recommending the inclusion of
psychosocial distress screening and appropriate treatment, creating a new standard of quality
cancer care. IOM standards provided recommendations for the effective delivery of psychosocial
health services within oncology settings. The proposed model of care begins with effective
communication between patients and their providers to screen and detect psychosocial needs.
Once needs are identified, providers are encouraged to connect patients and families to resources
and support, which may include internal or external services. A strength in this approach is its
reliance on the use of interdisciplinary collaboration to coordinate psychosocial and biomedical
care. Figure 1 provides an illustration of the cyclical model proposed by IOM (2008, p. 8).
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Effective Patient-Provider Communication
Patient/Family

Patient-Provider
Partnership

Provider Team

Identification of Psychosocial Needs

Development and implementation of a plan

Links patient/family
with needed psychosocial
services

Supports patients by:
o Providing personalized information
o Identifying strategies to address needs
o Providing emotional support
o Helping patients manage their illness
and health

Coordinates
psychosocial
& biomedical care

Follow-up &
re-evaluation

Figure 1. Model for the delivery of psychosocial health services. Reprinted with permission from
Cancer Care for the Whole Patient, 2008 by the National Academy of Sciences, Courtesy of the
National Academies Press, Washington, D.C.
Standards of practice for oncology social workers, the primary professional discipline
responsible for providing psychosocial services in cancer settings, expands upon IOM
recommendations to provide more detail regarding the role of clinicians delivering psychosocial
services. The Association of Oncology Social Work (2012) recommends clinical providers
possess knowledge of oncological disease and associated treatments to understand the
psychosocial implications for patients and family and appropriately support them in coping with
anticipated challenges and changes that occur. Clinicians are encouraged to explore patients’
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understanding of their disease, reactions, and expectations while also assessing the psychosocial
functioning of the patient and family including strengths, coping skills, socioeconomic resources,
and cultural and spiritual factors that may affect oncology care. Clinical providers are tasked
with identifying patients at high risk of suboptimal psychosocial functioning during their
treatment. Similarities can be seen in the recommendations proposed by AOSW in 2012 and the
psychosocial factors outlined by Wesiman, Worden, and Sobel in 1980 (as cited in Zabora et al.,
2001), demonstrating the resoluteness of psychosocial variables affecting healthy adaptation to
disease.
Implementation of standards and guidelines. In 2012, new accreditation standards for
cancer treatment centers were released by the Commission on Cancer of the American College of
Surgeons (ACoS); whereas previous standards were once recommendations, new accreditation
standards required all patients receive screening for psychosocial distress as part of routine care
(NCCN, 2016b). These most recent standards were subsequently endorsed by the American
Psychosocial Oncology Society (APOS), the Association of Oncology Social Work (AOSW),
and the Oncology Nursing Society (ONS).
NCCN (2016b) guidelines for the management of distress were intended to assist
oncology teams in identifying cancer patients with distress and/or psychosocial needs and
recommending appropriate treatment interventions. According to the established standards of
care, distress should be assessed, documented, and promptly treated at all stages of a patient’s
disease and throughout appropriate treatment intervals. The detection of distress begins with a
brief screening tool to identify distress levels (e.g., mild, moderate, severe) and specific areas of
distress (e.g., practical concerns, family problems, emotional difficulties, spiritual or religious
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concerns, physical problems, etc.). The reader may refer to Appendix A to review NCCN
(2016b) standards of care for distress management.
Subsequently, the NCCN (2016b) created the Distress Thermometer (DT) to quickly
identify sources of distress related to cancer. A standard, brief questionnaire format was used to
identify distress and psychosocial needs and assist in developing a plan to manage needs. While
screening is a critical component of psychosocial care, the DT was, more importantly, designed
to facilitate dialogue between providers and patients and to ensure that psychosocial needs do not
go unrecognized and untreated in busy ambulatory care settings. The oncology team is often the
first to detect psychosocial concerns and, thus, providers must handle these conversations with
compassion and sensitivity:
It is important for the oncology team to acknowledge and validate that this is a difficult
experience for the patient and that distress is normal and expected. Being able to express
distress to the staff helps provide relief to the patient and builds trust. (NCCN, 2016b, p.
MS-12)
Once psychosocial needs are identified, patients need access to appropriate referral
sources and treatment. Cancer patients are not a homogenous group with homogenous needs;
interventions must to be selected according to where patients are on the continuum of distress
and cancer-related needs. NCCN recommends psychological interventions that offer
psychoeducation, resources that promote medication management and healthy lifestyle choices,
counseling, relaxation strategies, and spiritual support. Additionally, psychosocial providers
should be prepared to assess patients’ capacity to make treatment decisions and concerns related
to safety. Table 1 outlines examples of psychosocial needs and corresponding services to treat
specific areas of distress, as proposed by IOM (2008).
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Table 1
Psychosocial Needs and Formal Services to Address Them
Psychosocial Need
Information about illness,
treatments, health, and
services

Health Services
• Provision of information, e.g., on illness, treatments, effects
on health, and psychosocial services, and help to
patients/families in understanding and using the information

Help coping with emotions
and accompanying illness and
treatment

• Peer support programs
• Counseling/psychotherapy to individuals or groups
• Pharmacological management of mental symptoms

Help in managing illness

• Comprehensive illness self-management/self-care programs

Assistance changing
behaviors to minimize impact
of disease

• Behavioral/health promotion interventions, such as:
- Provider assessment/monitoring of health behaviors
(e.g., smoking, exercise)
- Brief physician counseling
- Patient education, e.g., in cancer-related health risks and
risk reduction measures

Material/logistical resources

• Provision of resources

Help in managing disruptions
in work, school, and family
life

• Family and caregiver information
• Assistance with activities of daily living, chores
• Legal protections and services, e.g., under Americans with
Disabilities Act and Family and Medical Leave Act
• Cognitive testing and education assistance

Financial advice and/or
assistance

• Financial planning/counseling, including management of
day-to-day activities such as bill paying
• Insurance (e.g., health, disability) counseling
• Eligibility assessment/counseling for other benefits (e.g.,
Supplemental Security Income, Social Security Disability
Income)
• Supplemental financial grants

Note. Care for the Whole Patient, 2008 by the National Academy of Sciences, Courtesy of the
National Academies Press, Washington, D. C.
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Providence Regional Cancer Partnership
In 2007, Providence Regional Cancer Partnership (PRCP), also referred to as the Cancer
Partnership throughout, was founded in collaboration with four of the region’s leading healthcare
organizations: Providence Everett Medical Center, The Everett Clinic, Western Washington
Medical Group, and Northwest Washington Radiology Oncology Associates. PRCP was
established with the intent of creating an integrative outpatient treatment center where all aspects
of patient care could be provided in one building including: chemotherapy, radiation oncology,
clinical research, and integrative medicine where behavioral health services reside. PRCP’s
vision statement conveys the standard of care they have strived to provide, “[PRCP is] a
comprehensive, regional, state-of-the-art, single destination designed exclusively for the cancer
patient and family with integrated and seamless clinical, operational and business processes”
(PRCP, 2009, p. 1). An illustration of PRCP’s organizational structure is found in Appendix B.
As of 2013, the Cancer Partnership was recognized as the fourth largest cancer program
in the region based on the number of patients served annually (PRCP, 2015a). PRCP is
accredited by the Commission on Cancer which ensures high-quality cancer care based on datadriven performance measures overseen by the American College of Surgeons (2014). Indeed, the
Cancer Partnership recently achieved the Outstanding Achievement Award after attaining the
Approval Award with Commendation for three consecutive years (PRCP, 2015a). Additionally,
the Cancer Partnership is certified by the Quality Oncology Practice Initiative, a program
administrated by the American Society of Clinical Oncology to ensure high practice standards of
quality and safety through ongoing assessment (ASCO, 2016). PRCP’s adherence to these
standards speaks to its culture of excellence and commitment to continued self-examination and
improvement.

16
Patient population. PRCP treats a wide range of cancers and hematology disorders. The
Cancer Partnership employs specialists in medical oncology, radiation oncology, surgical
oncology, thoracic oncology, gynecologic oncology, and neurosurgery. The reader is encouraged
to refer to Appendix C, which outlines the expansive list of medical and support services offered
at PRCP during 2014.
During the 12 months this evaluation was conducted, PRCP saw 1904 new cancer cases,
which is consistent with the average number of patients treated in previous years. Fifty-six
percent of all new patients were female (n = 1067), while 44% were male (n = 837). The most
frequently diagnosed tumor sites included breast (n = 370, 19.4%), lung (n = 275, 14.4%),
prostate (n = 105, 5.5%), lymphoma (n = 92, 4.8%), bladder (n = 92, 4.8%), and uterine cancer
(n = 92, 4.8%). Patients with stage I cancer were most prevalent among new cancer cases
(n = 561, 29.5%), followed by stage IV (n = 375, 19.7%). PRCP’s patient population is looked at
more closely in the chapters that follow as this evaluation examined patient demographics and
trends in utilization of psychosocial program services. The reader may also refer to Appendices
D, E, and F for a comprehensive look at the patient population during the time of this evaluation,
including the incidence of cancer site by gender, stage, and insurance type.
Psychosocial Services. As the Cancer Partnership was being conceptualized in 2005, a
multidisciplinary task force was concurrently planning and developing the inclusion of
psychosocial services, which became known as the department of Patient Support Services
(PSS). The mission and goals of PSS were established in alignment with NCCN (2016b) clinical
practice guidelines for the management of psychosocial distress. At the time, psychosocial
support goals were identified as follows (PRCP, 2005a):
•

To assess the psychosocial needs of each newly diagnosed patient
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•

To help patients and their families cope more effectively with the rigors of cancer
treatment and follow-up

•

To connect patients and family members with appropriate community resources to
meet their needs

•

To be available as a resource to help patients manage distress throughout their
treatment

•

To ensure that all patients, family members, and caregivers receive access to
psychosocial services to support the best possible outcomes for persons affected by
cancer

PSS has become an internal behavioral health team tasked with addressing the
psychological and social distress likely to accompany cancer throughout all phases of the cancer
continuum including diagnosis, treatment, survivorship, terminal care, and bereavement. The
department’s strength resides in its ability to offer patients and family members a wide range of
support options, beyond distress screening required by governing oncology sanctions. While
distress screening measures help monitor the psychological acuity and health of the patient
population at PRCP, the department offers a multitude of support services and interventions to
help patients utilize the healthcare system more effectively, mitigate psychosocial distress, foster
positive coping strategies, and optimize functioning, as suggested by AOSW (2012) guidelines.
In-house onsite psychosocial services reflect many of the services recommended by IOM (2008)
and may include education and advocacy, crisis intervention, individual and family counseling,
formal and informal assessments, support groups and group therapy, case management and
community resourcing, and financial assistance. PSS works closely with integrative medicine to
provide holistic healthcare and psychosocial support to patients, family members, and caregivers
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five days a week. Many services are offered at no cost to patients or family members. The reader
may refer to Appendix G to review a copy of PRCP’s policy and procedure regarding access to
psychosocial services. Additionally, Appendices H and I provide the full list with descriptions of
support resources advertised at PRCP.
PSS strives to be an integral part of the interdisciplinary oncology team, contributing to
the overall treatment of person’s cancer. In 2015, psychosocial services were identified as an
area of focus and growth by PRCP’s clinical and administrative leaders with the goal of
promoting integrative medicine and Patient Support Services, inside and outside the organization
(PRCP, 2015a).
Distress management at PRCP. Since its inception, PRCP has been committed to
following guidelines for distress management set forth by the NCCN (2016b) and IOM (2008).
In compliance with standards, PRCP has implemented procedures for ascertaining cancer-related
distress for medical and radiation oncology patients during appropriate treatment intervals.
Psychosocial distress screening procedures are outlined as follows and a full copy of PRCP’s
policy and procedure can viewed as Appendix J (PRCP, 2012b).
Distress Assessment tool. PRCP uses a standard, paper-and-pencil patient questionnaire
modeled after the NCCN (2016b) Distress Thermometer to routinely monitor psychosocial
distress and assess the need for services. PRCP’s Distress Assessment (DA) questionnaire asks
patients to quantify their experience of distress during the past week. The term “distress” is
intentionally undefined so patients may freely interpret their experience of distress, physical,
emotional, or otherwise. Additionally, the DA inquires more specifically about several areas of
distress including, practical concerns, emotional problems, family difficulties, and spiritual
concerns. Patients may also request additional information about psychosocial resources (i.e.,
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Medicaid, Medicare, Social Security) and PRCP support programs (i.e., nutrition, support
groups, hospice care). Please refer to Appendix K to review a complete version of PRCP’s DA
questionnaire.
Procedures. All patients who receive treatment at PRCP are screened for distress
throughout their care, however, distress screening procedures vary based on the treatment
patients receive. Medical oncology patients receive a DA questionnaire on days they both meet
with their oncologist and receive infusion treatment. DA questionnaires may also be provided
during pivotal intervals of care such as treatment completion, disease remission, or disease
progression. By contrast, radiation oncology patients meet with their oncologist much more
frequently and, therefore, only receive a DA questionnaire the day of their intake appointment.
DA forms are generally screened on at least two occasions, first by a treatment provider
so that distress can be addressed during a patient’s office visit or treatment session, and second
by PSS staff for further follow-up. PSS staff assesses DA forms to “determine if there are any
psychological, behavioral, social, practical, financial, or spiritual problems that might interfere
with the patient’s ability to participate fully in their healthcare and adequately manage their
illness” (PRPC, 2012b, p. 2). More specifically, PSS staff identifies patients needing follow up
care based on distress levels greater than five on a scale of 0–10 or when patients request
resources or a desire to be contacted. Ideally, staff makes contact with patients in need of follow
up care in person at the Cancer Partnership or by telephone within 72 hours. Further assessment
is completed at that time and an attempt is made to connect patients with appropriate resources
and services, including interventions facilitated by PSS staff.
The inclusion of this a brief assessment tool helps PRCP providers detect and assist in
alleviating cancer-related distress and introducing patients to the spectrum of support services
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available to them. During PRCP’s first year as a free-standing cancer treatment facility, PSS
completed more than 4,479 DA questionnaires, with 22.6%, or 1,013 DA forms, indicating
distress levels greater than five (PRCP, 2009). The most frequently identified concerns at that
time were depression (n = 7.1%), fears and nervousness (n = 6.4%, n = 5.2%), and sleep (n =
4.3%). In 2013, a review of patient contact from three full-time PSS staff members
demonstrated that per each 1.0 staff position, 91 points of contact were made each month and an
average of 52 new patients were contacted each month (K. Johnson, personal communication,
2013).
Quality assurance. The NCCN (2016b) recommends systemic guidelines to ensure
distress management standards are implemented and monitored thereafter. Institutions are
encouraged to establish interdisciplinary committees to oversee distress management policies
and evaluate quality of psychosocial care. In doing so, the NCCN recommends an audit of
patient care records to (a) confirm a patient’s emotional wellbeing has been assessed and (b)
determine if any action was taken to address identified psychosocial needs. Systemic quality
improvement protocols are encouraged to provide feedback to oncology treatment centers about
the quality of psychosocial care including patient satisfaction and quality of life.
As a multidisciplinary center, PRCP has several committees that oversee best practices,
strategic, business, and program developments, and compliance with ACoS standards for cancer
treatment centers (the reader may find a full list of PRCP committees and their role in supporting
program goals in Appendix L). Each department has measures that evaluate patient satisfaction,
waiting times, and other indicators of quality care (PRCP, 2009). Some measures are compared
to other cancer treatment centers throughout the nation, while others are for internal use only.
Psychosocial programming and adherence to distress screening policy and procedures are
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overseen by the Medical Director of Psychosocial Services and reported annually to the
Multidisciplinary Cancer Committee Quality Assurance. In compliance with NCCN (2016b)
standards, patients beginning treatment are identified each month and electronic health records
are audited to see if distress screening has occurred within 30 days of treatment. Support group
attendance is also reported to the Cancer Partnership administration monthly.
In summary, the most current healthcare standards recognize high quality cancer care
reaches beyond biomedical treatment to require the inclusion of psychosocial care. Psychosocial
services are necessary to treat the complexity of physical, emotional, social, and economic
hardships expected to accompany cancer and the rigors of treatment. Psychosocial interventions
have demonstrated efficacy in helping patients adopt positive coping skills that can minimize
symptoms of distress and improve overall health (IOM, 2008). Patients who receive psychosocial
services in tandem with biomedical services tend to have better quality of living and a lower
likelihood of developing severe emotional disorders that can interfere with functioning and
healthcare treatment. In addition, these patients report greater satisfaction in their cancer care and
greater treatment compliance with provider recommendations (NCCN, 2016b).
In adherence with national initiatives, Providence Regional Cancer Partnership was
established as a multidisciplinary outpatient cancer treatment center to meet the biomedical and
psychosocial needs of its patients. The following chapters examine how PRCP has addressed the
psychosocial needs of its patient population. A program evaluation was conducted to understand
how program services delivered by Patient Support Services were (a) utilized and represented
across patient demographics and (b) valued or regarded within the larger cancer treatment center.
Program strengths provide insight into services that are well utilized and provide support for the
efficacy of psychosocial services as part of a larger cancer treatment center. Program
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recommendations are offered with input from stakeholders to improve areas of concern identified
by patients and staff.
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Chapter II: Methodology
While PRCP routinely employs internal quality assurance procedures dictated by the
American College of Surgeons (2014) and National Comprehensive Cancer Network (2016b),
the organization had not taken an in-depth look at its behavioral health department, Patient
Support Services, since it’s inception in 2007. In particular, to-date, no information had been
gathered that analyzes how program services are utilized and by whom; additionally, program
satisfaction data had not been collected since 2009. This evaluation sought to understand and
evaluate the merit of PRCP’s psychosocial services department and to provide program
feedback. A stakeholder meeting was held to generate areas of interest from the perspective of
PRCP’s leadership team as well as clinical and support staff. The nature of this evaluation
included gathering qualitative and quantitative data from patients and staff to understand how
program services were currently utilized and regarded from the perspective of program
recipients, clinical staff, and administrators. Evaluation findings provided informed and
contextualized recommendations to further benefit PRCP’s staff and patient population.
Program Evaluation
This study utilized program evaluation as a methodology to evaluate psychosocial
services provided at PRCP. As a method, program evaluation evaluates questions concerning a
program’s utilization, implementation, or efficacy of services (W. K. Kellogg Foundation,
2004a). At its core, program evaluation seeks to determine the merit of the subject being studied;
a judgment is rendered about the worth or value of the subject being studied. Herein lies the
primary difference in purpose between research and evaluation methods: Research contributes
information to a field by providing conclusions; whereas, evaluation aims to help stakeholders
make informed decisions based on judgments (Fitzpatrick, Sanders, & Worthen, 2004). Unlike
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research, which culminates in a discussion of how results are generalizable, program evaluation
concludes with a report of evaluation findings and program recommendation specific to the
organization.
Formative program evaluation. More specifically, a formative program evaluation
framework was used in this study based on the primary purpose and intended audience of the
evaluation. Formative evaluations intend to provide feedback for the purpose of program
improvement, providing information on the merit or worth of part of a program rather than the
entirety of a program (Fitzpatrick et al., 2004). Such evaluations focus on examining program
activities, outputs, and short-term outcomes to monitor progress and recommend midcourse
corrections as needed (W. K. Kellogg Foundation, 2004b). Questions typically asked throughout
a formative evaluation may include: What aspects of the program are working? What elements
need to be improved and how?
The intended audiences who will benefit from this evaluation are the people delivering
program services, namely Patient Support Services staff and program administration; program
recipients will benefit secondarily from recommendations aimed to improve program services.
Stakeholder Meeting
Engaging stakeholders in the evaluation process, particularly during the question
development phase, was prudent in ensuring a useful and credible project. Because stakeholders
are invested in the organization’s success and affected by the evaluation findings, their input was
necessary and invaluable in determining the scope and direction of this evaluation. As noted by
Preskill and Jones (2009), evaluation findings are more likely to be relevant, accepted, and
implemented by the organization when research questions reflect the interests and needs of
vested members.
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Members of the PRCP Psychosocial Steering Committee were invited to participate as
stakeholders. The Psychosocial Steering Committee is a multidisciplinary team responsible for
“planning and implementing program and service development to meet the psychosocial needs of
cancer patients” (PRCP, 2012a, p. 2). Because the committee oversees psychosocial program
development, the quarterly meeting was chosen as the forum to invite members to participate as
stakeholders in shaping the proposal of this project and brainstorming possible areas of
evaluation. In total, 10 members participated in the first stakeholder meeting including members
of the management team as well as supporting specialists and clinical staff. Although program
recipients may also be considered stakeholders as the beneficiaries of program services, patients
were not invited to stakeholder meetings because the primary audience of this evaluation was
persons delivering program services rather than its consumers.
Members present at the stakeholder meeting expressed support and enthusiasm for the
evaluation. Several areas of interest were generated and later categorized by the evaluator based
themes and areas of focus defined by Fitzpatrick et al. (2004): needs assessment or context,
process and monitoring, or outcomes. What follows are areas of evaluation proposed during the
stakeholder meeting (the reader may refer to Appendix M to review notes from the first
stakeholder meeting).
Needs assessment or context. This area of evaluation explores program aspects
perceived of being in need and attempts to mitigate problems through program
recommendations:
•

What is the purpose and value of Patient Support Services?

•

How does PRCP compare to other cancer treatment centers or Providence campuses
throughout the region?
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Process and monitoring. These questions seek to understand how program services are
delivered:
•

Is the current model of training and delivery of psychosocial program services
sustainable over time?

•

Is the mission of Patient Support Services still appropriate? Is the program doing
what we said it would and is it doing it well?

•

How are program services utilized by patients? Are there groups of patients not being
served by PSS?

Outcomes. Outcome questions explore how program recipients are changed through their
participation in a program:
•

What is the patient and/or staff experience of PSS?

•

What is the cost and savings benefit of the larger Cancer Partnership because of the
inclusion of psychosocial services in cancer treatment?

•

What is the impact of having PSS within the larger cancer treatment program and how
does if affect the role of other staff members?
Stakeholders continued to be involved throughout the development of this evaluation. A

second stakeholder meeting took place prior to data collection to discuss design considerations,
sources of available data, and data collection methods. The Medical Director of Psychosocial
Services was closely involved in all phases of this evaluation, ensuring program support and
interest throughout the entirety of the evaluation. Stakeholders were again included at the
conclusion of data analysis to participate in generating proposed program recommendations
based on evaluation findings.
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Outcomes Approach Logic Model
Following the initial stakeholder meeting, a logic model was developed to provide
clarity in understanding the presumed relationship between program services, program goals
defined by the department’s mission, and the desired outcome of program services. Logic models
visually depict the relationship between a program’s theory and assumptions about how the
program works (W. K. Kellogg Foundation, 2004b). More specifically, logic models are helpful
in illustrating the sequence of activities necessary to facilitate desired changes and bring about
anticipated results. In this way, logic models can serve as a roadmap to guide stakeholders and
the evaluator in understanding the relationship between the program’s goals and the results the
program expects to achieve.
For this evaluation, an outcomes approach logic model was chosen to illustrate the
assumed causal relationships between PSS program services and the program’s anticipated
outcome, to mitigate the psychosocial distress of cancer patients and their family members.
Appendices N and O illustrate the outcomes approach logic model used in this evaluation to
better understand the relationship between program services and desired outcomes.
Evaluation Questions
Evaluation questions were formulated with input from PRCP stakeholders and refined
using program evaluation theory and methodology. Formative program evaluation methods
provided the scope for this project, while an outcomes approach logic model provided clarity in
understanding the relationship between program activities or services (i.e., input) and desired
outcomes or expected results participating in services (i.e., output). Finally, project feasibility
was also considered when identifying evaluation questions. Congruent with formative evaluation
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practices, this evaluation aimed to provide feedback about particular aspects of PSS, rather than
the program as a whole.
The predominant purpose of this formative evaluation was to provide PRCP feedback
about the merit or worth of Patient Support Services. To this effect, the evaluator examined both
utilization and satisfaction of Patient Support Services to better understand how program services
were (a) utilized and represented across patient demographics and (b) valued or regarded within
PRCP, as defined by patient and staff satisfaction. A mixed method approach was used to collect
and analyze data. Archival data was gathered from electronic health records to determine how
program services were utilized and by whom. Two surveys were designed and distributed to
understand the experiences and opinions of program services.
Participants
Demographic information was collected from electronic health records to identify a
representative sample of patients who utilize program services. Additionally, program feedback
was collected from patients and staff members including program administrators, clinical
providers, and support staff persons.
Patient chart reviews. Four hundred chart audits were decidedly selected from an
overall sampling of patients who received cancer treatment at PRCP. Electronic health records
were chosen for review based on patient participation or interaction with PSS staff within twelve
months of this evaluation being conducted. Participants were selected from charting records
based on documentation of daily patient interactions provided by three PSS staff members.
Patient information was then located using PRCP’s data information system which manages
electronic health records. Participants were excluded if patient names were unable to be located
in the electronic health record. These names likely accounted for patients with misspelled names,
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family members calling on behalf of patients, or persons receiving treatment elsewhere but
calling PSS for information or resources. Additionally, participants were excluded if a cancer
diagnosis was unsubstantiated based on documentation (i.e., benign masses or tumors). On
occasion, hematology patients were included if they received treatment from an
oncologist/hematologist and participated in program services.
Patient surveys. Patients were also selected to receive surveys. This selection process
occurred a number of ways to account for patients who were currently receiving treatment as
well as patients who had completed treatment in recent months. Patients were offered satisfaction
surveys if they were receiving treatment onsite during a four month period while this evaluation
was being conducted. Patients attending a support group during this evaluation were also invited
to participate in surveys. Lastly, patients were selected to receive a survey by mail if they had
attended an initial oncology office visit in the year prior to this evaluation being conducted.
Known deceased patients were excluded from the mailing list.
Staff surveys. PRCP staff was invited to participate in an online survey to gather
feedback about Patient Support Services. Staff who had direct or indirect interaction with
patients and/or PSS staff were eligible to participate in the survey. Staff members included
program administrators, clinical providers, and support staff persons. Members of Patient
Support Services were excluded.
Materials and Measures
Chart reviews. Demographic information was collected from electronic health records
to better understand how program services were currently represented and utilized by patients.
Patient demographics were defined and described as follows:
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Age. Age was determined at the time of data collection according to date of birth. Age
was then collapsed into groupings by age range as follows: 18–25, 26–34, 35–44, 45–54, 55–64,
65–75, 75 and older.
Gender. A binary gender classification was used to categorize patients as either male or
female based on documentation gathered from electronic health records.
Insurance. Primary health insurance information was collected and then collapsed into
three categories: private or commercial, Medicare, and Medicaid or state-sponsored insurance.
Insurance information was used to generate inferences about socioeconomic status and access to
resources.
Cancer type. Type of cancer, or primary cancer site, was determined by the oncology
team. Diagnoses were identified according to an initial oncology appointment and confirmed
based on the most recent office visit to account for any diagnostic changes that may have
occurred based on later imaging and pathology findings. In 2015, PRCP treated the following
primary cancers:
•

Bladder cancer

•

Brain tumors

•

Breast cancer

•

Cervical cancer

•

Colorectal cancer

•

Endometrial cancer

•

Esophageal cancer

•

Gallbladder cancer

•

Gastrointestinal tumors
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•

Head and neck cancer

•

Kidney cancer

•

Leukemia

•

Liver cancer

•

Lung cancer

•

Lymphomas

•

Ovarian cancer

•

Pancreatic cancer

•

Skin cancer

•

Soft tissue sarcoma

•

Uterine cancer

Several oncologists at PRCP also treat a variety of hematologic malignancies or blood diseases,
including problems affecting blood cells, platelets, blood vessels, bone marrow, lymph nodes,
and proteins that affect bleeding and clotting (American Society of Hematology, 2015).
Hematology patients also had access to Patient Support Services and, therefore, were included in
this evaluation on the rare occasion that they participated in program services.
In general, International Classification of Diseases (ICD-9CM) (WHO, 2015) coding
system was used to classify cancers based on primary site. For analysis, less commonly
occurring cancers and malignant disorders were grouped together by their relationship as
follows:
•

hematologic diseases: anemia, coagulation disorder, thrombocytosis and
thrombocytopenia, and myelodysplastic syndrome;

•

blood cancers: lymphomas, leukemias, multiple myeloma;
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•

female reproductive cancers: vaginal and vulvar, cervical, uterine and endometrial,
ovarian, and urethral cancer;

•

male reproductive cancers: penile, prostate, and testicular cancer;

•

head and neck cancers: oral cavity, pharynx, larynx, paranasal sinuses and nasal
cavity, salivary glands, and thyroid cancer;

•

skin cancers: basal and squamous cell, melanoma, merkel, and Kaposi;

•

colon, rectal, and intestinal cancer;

•

liver and hepatocellular cancer and bile duct cancer; and

•

squamous cell carcinoma of unknown primary site

Cancer staging. Clinical stage was determined at diagnosis by the oncology team, prior
to starting treatment. Staging describes the progression and severity of cancer based on the size
of the tumor and the extent cancer has spread beyond the original tumor into nearby tissues and
organs or into the bloodstream or lymphatic systems (ACS, 2015b). Staging provides inferences
about treatment options as well as prognosis, including chance of survival and the likelihood of
cancer recurring. Most cancers are classified as one of five stages, with higher stages indicating
more extensive disease progression (National Cancer Institute at the National Institutes of Health
[NCI], 2015):
•

Stage 0: Abnormal cells are present, but have not spread to nearby tissue. At this
stage, abnormal cells are not cancerous, but may later become cancer.

•

Stage I: Cancer growth is limited to the primary organ site without evidence of
metastases, or growth beyond the original tumor.

•

Stages II & III: Cancer has spread beyond the primary organ to nearby lymph nodes,
tissues, and/or organs.
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•

Stage IV: Cancer has spread to distant lymph nodes, tissues, and/or organs.

There are several exceptions to the staging classification system described above. For
example, cancers of the blood or bone marrow rely on a different staging system that considers
blood cell counts and may use a three-stage classification system (0–III) rather than five (ACS,
2015a; ASCO, 2015; Leukemia and Lymphoma Society, 2015). Because a variety of factors
determine cancer staging, including the number of staging classifications (typically three verses
five), true comparisons between cancer stages across cancer types could not be made. However,
during data analysis, it was assumed that higher stage numbers were indicative of more extensive
disease progression, irrespective of cancer type or classification system.
Medical treatment. PRCP (2014) provides a wide variety of medical treatments including
prevention screening, diagnostic services, clinical research, medical oncology, radiation
oncology, and psychosocial services. This evaluation identified whether patients received
surgical oncology, chemotherapy, radiation, or a combination of medical services. Data analysis
looked at trends in the utilization of program services according to medical oncology treatment.
Program services. Participation in program services was recorded based on
documentation from PSS staff. While PRCP offers a variety of support services and integrative
medicine including acupuncture, yoga, hypnosis, meditation, and naturopathic medicine, this
evaluation focused on services provided by PSS staff. Namely, this evaluation was interested in
tracking patient interaction related to telephone contact, Distress Assessment questionnaires,
supplemental financial services, counseling during infusion, office visits, support groups, and
family involvement in services. Information was also collected about patient participation in the
Cancer Resource Center and nutrition services because of the close involvement the patient
navigator and dietician had with PSS. Support groups facilitated by PSS staff were included;
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however, data was not collected from the Look Good, Feel Better class facilitated by the
American Cancer Society, the prostate cancer support group facilitated by a cancer survivor, or
gentle yoga led by yoga instructors unaffiliated with PSS.
The number of interactions with PSS was determined based on staff documentation; any
interaction with PSS staff, the patient navigator, or dietician was included for data analysis and
not limited to a specific timeframe. While patient participation in support groups was included,
the number of times a patient attended a support group was not calculated
Surveys. Two surveys were designed to gather information from the perspective of
patients, or program recipients, and staff members. Surveys were developed with input from PSS
staff and designed to elicit respondents’ experiences and opinions about program services and
staffing, drawing out program strengths and weaknesses. Respondents’ attitudes were measured
using fixed-choice Likert scales intended to increase the likelihood and ease of participating in
surveys.
Patients were asked about their familiarity with the department and program services,
utilization of services, satisfaction regarding the quality and variety of program services as well
as staffing, opinions about the impact program services had as part of their cancer care treatment,
and perceived strengths and areas for improvement. Similarly, PRCP staff were surveyed about
their familiarity with the department and program services, the referral process (how often,
which services, and under what circumstances program services were recommended by staff),
perceived strengths and areas for improvement, and opinions about the importance or value of
including behavioral health services in a cancer treatment program. Copies patient and staff
satisfaction surveys are included as Appendices P and Q.
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Procedures
Patient chart reviews. Four hundred electronic health records were reviewed to gather
information on patient demographics, general treatment information including cancer origin and
stage, treatment modalities, and participation in Patient Support Services. Information was
gathered from electronic health records, particularly physician treatment notes, PSS staff
documentation, and patient demographic information.
Patient surveys. Patient surveys were distributed both in person and by mail to capture a
large pool of participants and to mitigate low return rates typical of surveys. Surveys were
initially offered to patients by reception staff upon checking in for chemotherapy or radiation
treatment. A secure box was provided to anonymously return completed surveys in common
waiting areas. However, due to a low volume of surveys returned in person, surveys were mailed
to patients’ homes. Preaddressed envelopes with prepaid postage were included for easily return
completed surveys to PRCP. Four hundred and forty surveys were mailed to patients who began
treatment between July 1 and October 1, 2014. This treatment timeframe was selected to avoid
sending surveys to patients who were currently receiving treatment onsite, minimizing the
possibility of surveying people on more than one occasion.
In addition, American Cancer Society volunteers offered surveys to patients during
chemotherapy infusion. It was conceived that patients would be more likely to complete surveys
during treatment, which often lasts several hours, rather than during an office visit with their
oncologist. Presumably, patients would be more receptive to complete surveys hand-delivered by
volunteers during treatment than by reception who routinely distribute patient paperwork upon
checking in. Lastly, PSS staff distributed surveys during support group meetings between
August–September 2015. In total, 590 surveys were made available for distribution in person and
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by mail. Patient surveys were printed on colored paper to monitor how surveys were returned
and by whom.
Staff surveys. One hundred and ten eligible staff were invited to anonymously
participate in a survey via Survey Monkey. An initial email invitation read, “Please consider
participating in the following survey to provide feedback about Patient Support Services. Your
input is extremely valuable in shaping ongoing and future services. Your participation is
voluntary and anonymous. It should take no longer than ten minutes to complete. Thank you for
your feedback.” A second email invitation was sent by the evaluator 2–4 weeks later with the
following request, “Patient Support Services needs your feedback. If you have not already
responded, please complete the survey using the link below. We are very interested in hearing
from you so we can strengthen and improve services we provide to our patients each year. It is a
quick anonymous survey, but your feedback is invaluable. Thank you.”
Data Analysis
Data from electronic health records and surveys were analyzed to (a) identify trends in
the utilization of program services and the patients who use them, and (b) draw out themes
regarding the quality, variety, and efficacy of program services and staffing. Data analysis
decisions were informed by the goals of this evaluation with the intention of providing feedback
to staff delivering program services and administrators. Additionally, data analysis was informed
by the characteristics and statistical assumptions of the data set (Salkind, 2007).
Chart reviews. Data collected from electronic health records was recorded into Excel for
tracking, coding, and analysis. Utilization of services data relied heavily on the use of descriptive
statistics to describe the characteristics of program participants and services used. A majority of
the data collected was categorized as a nominal level of measurement including gender,
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insurance information, cancer diagnosis, and program services. Ordinal (cancer stage) and ratio
levels of measurement (age, number of PSS visits) were less likely to characterize the data set.
Participants were categorized into three groups based on their level of participation in program
services, as described in the following chapter on evaluation results. Descriptive statistics were
used to describe the characteristics of each participant group and make comparisons between
groups to understand how services were used. Frequency charts were used to visually depict the
occurrence of demographics and to illustrate the majority and minority characteristics of program
users. Percentage rates and frequencies were often reported together to describe the
characteristics of data; percentage rates demonstrated frequencies in relation to the sample
population. Measures of central tendency described the average age range, the mean cancer
stage, and average number of program services used.
Inferential statistics were used to compare data to other points of reference.
Nonparametric statistics allowed the data to be examined based on rules of distribution and the
relationship between variables (Salkind, 2007). This data set relied on one-sample chi-square
analyses to make inferences about demographic information compared to PRCP’s patient
population at-large. When appropriate, chi-square analyses were also conducted to compare the
distribution of demographics between program participants and corresponding national data.
Surveys. All survey data was entered in SurveyMonkey for analysis. Similar to chart
reviews, survey data heavily relied on descriptive statistics to explain findings. Demographic
information was collected to describe the representative patient and staff sample. Frequency
charts and pie charts were used to visually represent results; while frequency charts illustrated
the overall tally of a variable, pie charts demonstrated values in proportion to the sum of the data.
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The majority of survey questions measured respondents’ attitudes towards a statement
using fixed-choice Liket-scales. Data from Likert-scales was represented using percentage rates
and frequencies to quantify responses. Other questions contained multiple choices and
respondents were free to select as many that applied. Again, percentage rates and frequencies
depicted how often a response was endorsed and how it compared to the overall sample. Lastly,
one open-ended question solicited feedback about suggested program areas for improvement.
Responses were synthesized into shared categorizes based on observed themes and reported
using respondents’ language.
Risks and Ethical Considerations
Patients. The presumed risks of participating in surveys was deemed minimal, though
worthy of consideration. First, cancer patients may be perceived as a vulnerable population given
the acuity and/or chronicity of their disease and their dependence on medical providers for
appropriate treatment (Managed Care and Healthcare Communications, 2006). The vulnerability
of participants is further realized as additional factors are taken into account such as race, gender,
socioeconomic status, education, and level of psychosocial distress or mental illness. As a
vulnerable population, patients may have felt uncomfortable participating or unable to decline
participating. Patients may have felt pressure to participate in this evaluation given the difference
in power and status between patients and their providers. Although participation was voluntary
and feedback was anonymous, patients may have felt uncomfortable or guilty providing critical
feedback because of their reliance on the institution for life-prolonging treatments. Critical
feedback may have been inhibited for fear of repercussions if patients expressed criticism of an
organization they depend on for care.
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Staff. PRCP staff faced similar risks participating in this evaluation. Most notably, PRCP
staff may have been reticent to participate for fear of being identified and experiencing
retaliation. While the staff survey was designed to be anonymous, staff were asked to identify
their position and number of years employed, which threatened their anonymity. For example,
some staff positions, such as advanced care practitioners, represented a very small portion of
overall staff and, thus, such identifiers significantly reduced the anonymity of staff. A second
consideration was the dual relationships this evaluator had with several staff members which is
discussed further in the next section. Dual relationships may have compromised respondents’
objectivity or ability to provide critical feedback.
Disclosure of roles and relationships. From 2013–2014, I was a full-time predoctoral
psychology intern in Patient Support Services at PRCP. Following the completion of my
internship, I obtained employment with The Everett Clinic, one of the organizations that
comprise the partnership of PRCP. I have maintained personal and professional relationships
with many of the people I worked with at PRCP, including current PSS staff and the Medical
Director of Psychosocial Services, Dr. Kathryn Johnson who helped facilitate this evaluation and
served as a committee member for my dissertation defense.
My involvement in PSS created advantages and disadvantages as an internal evaluator.
Foremost, the decision to evaluate the efficacy of PSS grew out of my personal involvement with
the organization and my affection for the program’s mission to mitigate the psychosocial distress
of persons affected by cancer. As a former intern, my relationships with the staff at-large
facilitated a trusting and collaborative atmosphere; relationships that were cultivated years prior
helped foster the necessary involvement of staff as vested stakeholders who shaped the
development, execution, and utility of this evaluation. My intentions to evaluate the program
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were also assumed to be benevolent and beneficial. I was regarded as an expert of psychosocial
services based on my intimate knowledge and experience of the department’s workings including
program development and services, the history, mission, and goals of the program, the patient
population, and PSS’s position within PRCP. Further, my understanding of the organization’s
systemic and political values helped design an evaluation that was of interest to PRCP and in
alignment with their goals and mission.
Conversely, my role as an internal evaluator could also be viewed unfavorably. While my
history with the program helped facilitate the execution of this evaluation, it also contained a
biased perspective. Whereas an external evaluator may have brought a more objective and
arguably more credible perspective to the evaluation process, my relationship with the
organization likely influenced the interpretation of the results. Indeed, my affinity for the
program and its success likely influenced how feedback was interpreted and later integrated into
recommendations. It is likely I analyzed program feedback with an “opportunistic bias,”
unconsciously searching for feedback that confirmed own ideas about the program’s strengths
and weaknesses (De Coster, Sparks, Sparks, Sparks, & Sparks, 2015). To account for evaluator
bias, participants were invited to offer explicit feedback about their perception of program
strengths and weaknesses, openly encouraging critical feedback. Additionally, stakeholders
participated in interpreting findings and formulating recommendations, which helped provide a
more pluralistic understanding of feedback and challenge the evaluator’s preconceived notions
about expected findings.
As an internal evaluator, I had little insulation when it came to scrutinizing data and
presenting results to the organization. Critical feedback needed to be presented accurately and
thoughtfully without fear of jeopardizing my relationships within the organization. Additionally,
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dual relationships with staff as both participants and colleagues or friends blurred the boundaries
of the evaluation at times, especially as the design and scope of this evaluation were considered.
Limitations of this evaluation had to be identified and clearly negotiated early on to establish the
parameters of this project and shield the evaluator from potential repercussions. Again, the close
involvement of stakeholders proved essential in conducting an evaluation that was fair and
mutually agreed upon. Further, the involvement of stakeholders throughout the entirety of this
evaluation reduced elements of surprise or confusion and prepared stakeholders for constructive
findings at the conclusion of the evaluation.
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Chapter III: Results
Results of this evaluation provided Providence Regional Cancer Partnership feedback
about the merit or worth of Patient Support Services. To this effect, the evaluator examined both
utilization and satisfaction of PSS to better understand how program services were (a) utilized
and represented across patient demographics and (b) valued or regarded within the cancer
treatment center. Results provided a snapshot of program services as they were currently utilized
and valued from which informed recommendations were generated based on perceived program
strengths and areas for improvement.
Utilization of Services
Demographic information was collected from PRCP patients to better understand how
program services were currently represented and utilized. Information was gathered from the
electronic health record of 400 patients who participated in a least one program service during
the 12 months prior to this evaluation. Information was collected on patient demographics (age,
gender, insurance information), general diagnostic information (cancer origin and stage),
treatment modalities (surgery, chemotherapy, radiation), and participation in program services
(telephone contact, distress assessment, Cancer Resource Center, nutrition services, financial
services, support during infusion, office visit, support groups, family services).
Demographics of patients who participated in program services were compared to
demographics of all new patients at PRPC during the same timeframe. Program recipients were
categorized into three groups for analysis based on their level of participation in program
services, defined as follows: (a) single-use participants: patients who participated in program
services once (n = 89), (b) multiuse participants: patients who participated in program services
on more than one occasion (n = 212), and (c) group participants: patients who participated in one
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or more support groups (n = 99). Demographic information was analyzed to understand how
utilization of program services compared and contrasted among the three groups. Data was then
aggregated again to further compare program services between groups.
All new cancer cases. According to the American Cancer Society (ACS, 2014a), there
were 38,230 new cancer cases in Washington State in 2014. During the time of this evaluation,
PRCP saw 1,904 new cancer cases. Of those, 44% were male and 56% were female. Patients
were most likely to be between the ages 60–69 (n = 30%). Patients between the ages 70–79 were
also highly represented, constituting 25% of all new patients. Patients under the age of 49
represented 13% of all new cases.
Table 2
Percentage Rates and Frequency of Demographics: New Cancer Cases
Percentage

Frequency

Gender
Male
Female

44.0%
56.0%

837
1,067

Participants Age
0 to 29
30 to 39
40 to 49
50 to 59
60 to 69
70 to 79
80 to 89
90 or older

2.1%
3.0%
8.0%
19.0%
30.2%
24.6%
11.1%
2.0%

40
58
153
360
575
469
211
38

According to national statistics on gender and cancer incidences reported by ACS
(2014b), the number of all new cancer cases per men was 855, 220 (n = 51.3%), while new
cancer cases per women was 810, 320 (n = 48.7%). A chi-square analysis was conducted to
determine if the distribution of men and women constituting new cancer cases at PRPC was
meaningful or likely due to chance based on ACS (2014b) national gender and incidence rates.
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Results from the chi-square analysis suggested the distribution of men and women was
meaningful (X2(1) = 41.06, p < 0.05). Indeed, PRCP observed lower frequencies of men
(n = 44%) and higher frequencies of women (n = 56%) than expected according to national
averages.
The age range of new patients seen at PRCP was roughly compared to national estimates
of all cancer cases based on ACS (2014b) data. An exact comparison was not possible due to the
different intervals used to calculate age ranges. Even so, differences between PRCP cancer cases
and national data could be inferred. While national data estimated persons older than 65
represent the majority of new cancer cases (n = 54.3%), PRPC’s greatest range of new cancer
cases was represented by patients age 50–69 (n = 49.1%). Presumably, PRCP saw a higher
incidence of new cancer cases among persons age 50–69 than estimated according to ACS
statistics (n = 37.2%) and fewer incidences of new cancer cases among persons older than 70.
National Statistics & Observed Frequencies: Gender & Age
ACS
51.3%
44.0%

PRCP

56.0%
48.7%

49.1%
37.2%

8.5%

Male

Female

54.3%
37.7%

13.2%

< 45 (ACS), < 49 45-64 (ACS), 65 + (ACS), 70+
(PRCP)
50-69 (PRCP)
(PRCP)

Figure 2. National statistics and observed frequencies: gender and age. Estimated new cancer
cases by gender and age, American Cancer Society (2014b).
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Table 3
Chi-square Analysis: New Cancer Cases by Gender
(O) Observed
Frequency

(E) Expected
Frequency*

(D) Difference

(O-E)2

(O-E)2/E

Men
837
977
140
19,531
20.00
Women
1,067
927
-140
19,531
21.06
Note. Expected frequencies were based on American Cancer Society (2014b) statistics of new
cancer cases by gender.
Among all new cases of cancer seen at PRCP, more than fifty percent of patients had
Medicare insurance as their primary payer (n = 1002). High incidences of Medicare coverage
coincided with the average age range of patients seen at PRCP, the majority being older than 60
(n = 1293). Because most people age 65 and older qualify for Medicare coverage (Centers for
Medicare & Medicaid Services, 2014), and 68% of all new cancer patients at PRCP were over
the age of 60, it was not surprising that 54% of all new cancer patients possessed Medicare
insurance. Of all new cancer cases, 38% of PRCP patients possessed commercial coverage while
7.5% had Medicaid (see Appendix F for a full report, PRCP Incidence of Cancer by Site and
Primary Payer Report).
In general, patients’ health insurance coverage differed from the distribution of health
insurance across the general population. According to the U. S. Census Bureau, 55.4% of the
general population possesses private health insurance, 16% receive Medicare, and 19.5% receive
Medicaid (Smith & Medalia, 2015). Comparatively, PRCP’s sample was represented by 38.1%
commercial insurance users, 53.6% Medicare, and 7.5% Medicaid recipients. While the large
variance of Medicare users could be attributed to the high volume of persons diagnosed with
cancer later in life, commercial and Medicaid users still appeared to be underrepresented, even
when patients over the age of 60 were excluded from the sample (n = 611). In particular, based
on U. S. Census Bureau estimates, Medicaid users appeared to be especially underrepresented
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among new cancer cases at PRCP. This discrepancy may reflect the organization’s decision to
restrict the number of persons accepted for treatment with Medicaid coverage.
Primary Insurance
All New Cases (N = 1869)
1002
725

142

Commercial

Medicare

Medicaid

Figure 3. Distribution of primary insurance: all new cancer cases.
In 2014, the most commonly occurring cancers at PRCP were breast (n = 370) and lung
(n = 275). Female reproductive (n = 178), blood cancers (n = 163), and colorectal cancer
(n = 151) were also well represented among new cancer cases. Pancreatic (n = 36), brain
(n = 33), and liver cancers (n = 25) were less common among new cancer cases.
The National Cancer Institute (NCI, 2016) projects breast, lung, prostate, colorectal,
bladder, melanoma, renal, leukemia and lymphoma, endometrial, and pancreatic cancers to be
the most common cancers among new cancer cases diagnosed in 2016. A chi-square analysis
was conducted to compare all new cancer cases at PRCP to expected prevalence rates across the
United States. Specifically, a chi-square analysis was used to determine if the distribution of
observed cancer cases at PRCP was representative of national cancer prevalence rates predicted
by NCI. Results from the chi-square analysis suggested the distribution of cancer among all new
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cases was not due to chance alone, indicating discrepancies between expected and observed
prevalence rates (X2(11) = 245.87, p < 0.05). Indeed, compared to national estimates, PRCP saw a
greater number of breast, lung, and female reproductive cancers than was expected. Conversely,
PRCP saw fewer male reproductive cancer patients than expected. The remaining cancer types—
brain, head and neck, liver, pancreatic, bladder, colorectal, blood, and skin cancers —appeared to
be representative of expected prevalence rates.
Cancer Type
All New Cases (N = 1634)
370
275
119
33

25

36

92

151

Figure 4. Distribution of cancer type: all new cancer cases.
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Table 4
Chi-Square Analysis: Cancer Type Among All New Cancer Cases
(O) Observed
Frequency

(E) Expected
Frequency*

(D) Difference

(O-E)2

(O-E)2/E

Brain
33
23
-10
102
4.48
Head & Neck
119
137
18
333
2.43
Lung
275
217
-58
3,327
15.30
Breast
370
229
-141
19,949
87.20
Liver
25
36
11
120
3.33
Pancreas
36
49
13
170
3.46
Bladder
92
74
-18
341
4.64
Colorectal
151
141
-10
110
0.78
Female
178
93
-85
7,202
77.32
Reproductive
Male
123
225
102
10,505
46.59
Reproductive
Blood
163
160
-3
8
0.05
Skin
69
74
5
21
0.28
Note. Expected frequencies were based on the occurrence of cancer subtype as compared to all
new cancer cases estimated in 2015, as indicated by the National Cancer Institute (2016).
The distribution of cancer stage was difficult to predict as cancer staging varies based on
cancer type (i.e., breast verses lung cancer) and available cancer screening or detection methods
(Canadian Partnership Against Cancer, 2016); therefore no comparison data were available to
determine differences in the distribution of cancer staging between all new cancer cases at PRCP
and expected values.
The majority of all new cancer cases were represented by stage I cancer (n = 29.5%).
Stage II and stage IV cancer were similarly represented among new cancer cases as 17.1% and
19.7%, respectively. Stage III cancer was less likely to be represented among new cancer cases,
second to stage 0 cancer.
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Cancer Stage
All New Cases (N = 1621)
561

375

326
234
125

Stage 0

Stage I

Stage II

Stage III

Stage IV

Figure 5. Distribution of cancer stage: all new cancer cases.
Single-use program participants. Eighty-nine participants used services on one
occasion with no additional follow up. Forty-two percent of single-use participants were male,
while 58% were female. The majority of single-use participants were between the ages 65–74
(n = 36%) and the mean age was 66.9 (median = 68, mode = 68). An additional 26% of singleuse participants were 75 or older while 24% were between the ages 55–64. Single-use
participants were less likely to be under the age of 54 (n = 15%).
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Table 5
Percentage Rates and Frequency of Demographics: Single-Use Participants
Percentage

Frequency

Gender
Male
Female

41.6%
58.4%

37
52

Participants Age
26 to 34
35 to 44
45 to 54
55 to 64
65 to 74
75 or older

1.1%
3.4%
10.1%
23.6%
36.0%
25.8%

1
3
9
21
32
23

Not surprisingly, because of its prevalence among all new cancer cases at PRCP, breast
cancer was well represented among single-use participants. The majority of single-use
participants were diagnosed with breast cancer (n = 25), while lung (n =12) and colorectal
cancer (n =11) represented the second and third most prevalent cancer types among single-use
participants. The remaining 64 participants represented a variety of cancer diagnoses.
Because all patients receive screening for psychosocial distress based on NCCN (2016b)
standards, single-use participants were expected to broadly represent cancer types relative to the
demographics of all cancer cases treated at PRCP. A chi-square analysis was conducted to
determine if the distribution of cancer diagnoses among single-use participants was
representative of new cancer cases at PRCP. Results from the chi-square analysis, did in fact,
suggest the distribution of cancer among single-use participants was equal to what was expected
compared to PRCP data on all cancer cases (X2(10) = 15.20), although breast cancer was
significantly represented more frequently than expected.

51

Cancer Type
1 Visit Only
25
12
4

11
3

1

2

6

9

8

4

4

Figure 6. Distribution of cancer type: single-use participants.
Table 6
Chi-Square Analysis: Cancer Type Among Single-Use Participants
(O) Observed
Frequency

(E) Expected
Frequency*

(D) Difference

(O-E)2

(O-E)2/E

Head & Neck
4
5
-1
2
0.38
Lung
12
12
0
0
0
Breast
25
16
9
72
4.39
Liver
3
1
2
4
3.25
Pancreas
1
2
-1
0
0.23
Bladder
2
4
-2
4
1.06
Colorectal
11
7
4
18
2.73
Female
6
8
-2
4
0.46
Reproductive
Male
9
5
4
13
2.33
Reproductive
Blood
8
7
1
0
0.07
Skin
4
3
1
1
0.29
Note. Expected frequencies were calculated based on observed frequencies of cancer type among
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix F for a
full report, PRCP Incidence of Cancer by Site and Primary Payer Report).
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For single-use participants, the mean stage was 2.56 (median = 3, mode = 4) with stage
IV occurring most frequently. Similar to cancer type, because all patients receive psychosocial
screening at PRPC and, therefore, presumably interact with PSS staff on at least one occasion,
cancer stage was expected to be evenly distributed relative to PRCP patient demographics.
A chi-square analysis was conducted to determine if the distribution of cancer stage
among single-use participants was meaningful compared to demographics of all new cancer
cases. Results from the chi-square analysis suggested the distribution of single-use participants
based on cancer stage was not due to chance alone (X2(3) = 17.89, p < 0.05). Indeed, single-use
participants with stage IV cancer were represented far more frequently than statistically
expected, while stages I–III were represented as expected compared to PRCP statistics.

Cancer Stage
1 Visit Only
32

22
13

13
5

4

Stage 0

Stage I

Stage II

Stage III

Figure 7. Distribution of cancer stage: single-use participants.
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Table 7
Chi-Square Analysis: Cancer Stage Among Single-Use Participants

Stage I
Stage II
Stage III
Stage IV

(O) Observed
Frequency

(E) Expected
Frequency

(D) Difference

(O-E)2

(O-E)2/E

22
13
13
32

24
14
10
16

-2
-1
3
16

3
0
10
264

0.11
0.03
1.01
16.73

The majority of single-use participants engaged in program services for the purpose of
distress assessment (n = 70), which was extremely likely because all patients receive
psychosocial distress screening as mandated by NCCN guidelines (2016b). Of note, 17% of
single-use participants involved family members (n = 15). Minimal single-use or first time
interactions with PSS occurred during infusion treatments (n = 3) or during office visits (n = 7),
which likely reflected the way patient referrals were made to PSS and, thus, how patients were
first introduced to program services.
Distribution of Program Services
1 Visit Only
70

9
Phone Contact

3
Distress
Assessment

Infusion Visit

7
Office Visit

Figure 8. Distribution of program services: single-use participants.
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Multiuse program participants. Two hundred and twelve participants used program
services on more than one occasion. Thirty-six percent of multiuse participants were male, while
64% were female. The majority of multiuse participants were between the ages 55–64 (n =
35%), representing a slightly younger patient demographic than single-use participants. The
mean age was 61.4 (median = 61, mode = 62). Twenty-three percent of multiuse participants
were ages 65–74, 20% were ages 45–53, and 16% were 75 or older. Fewer than 7% of multiuse
participants were under the age of 45.
Table 8
Percentage Rates and Frequency of Demographics: Multiuse Participants
Percentage

Frequency

Gender
Male
Female

36.3%
63.7%

77
135

Participants Age
18 to 25
26 to 34
35 to 44
45 to 54
55 to 64
65 to 74
75 or older

0.5%
1.9%
4.2%
19.8%
35.4%
22.6%
15.6%

1
4
9
42
75
48
33

Breast cancer patients were highly representative of multiuse participants, representing
the majority of users (n = 50), which mirrored high prevalence rates of breast cancer among all
new cancer cases at PRCP, in general. Lung cancer, which was second most prevalent among all
new cancer cases at PRCP, was also well represented among multiuse participants (n = 39), as
were head and neck (n = 23) and blood cancers (n = 27).
A chi-square analysis was conducted to determine if the distribution of cancer types
among multiuse participants was equal to what would be expected relative to statistics of all
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cancer cases treated at PRCP. Results from the chi-square analysis suggested the distribution of
cancer types among multiuse participants was not due to chance (X2(12) = 32.94, p < 0.05),
indicating differences between multiusers and PRCP’s general patient population. Even when
high prevalence rates were accounted for among all cancer cases, breast and lung cancer patients
were still represented more frequently than expected when compared to PRCP’s patient
population. Additionally, head and neck, pancreatic, and blood cancers were represented more
frequently among multiuse participants than predicted. Bladder cancer, on the other hand, was
represented less frequently than expected. The remaining cancer types—glioblastomas, liver,
kidney, colorectal, female and male reproductive cancer, and skin cancer—appeared to mirror
expected prevalence rates.
Cancer Type
2+ Visits
50
39
27

23
5

2

8

16
3

2

Figure 9. Distribution of cancer type: multiuse participants.
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Table 9
Chi-Square Analysis: Cancer Type Among Multiuse Participants
(O) Observed
Frequency

(E) Expected
Frequency*

(D) Difference

(O-E)2

(O-E)2/E

Glioblastoma
5
4
1
2
0.64
Head & Neck
23
13
10
96
7.31
Lung
39
30
9
87
2.94
Breast
50
40
10
101
2.52
Liver
2
3
-1
0
0.17
Pancreas
8
4
4
17
4.27
Kidney
3
6
-3
9
1.48
Bladder
2
10
-8
62
6.29
Colorectal
16
16
0
0
0
Female
16
19
-3
10
0.52
Reproductive
Male
11
13
-2
5
0.36
Reproductive
Blood
27
18
9
86
4.87
Skin
4
7
-3
12
1.57
Note. Expected frequencies were calculated based on observed frequencies of cancer type among
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix
F for a full report, PRCP Incidence of Cancer by Site and Primary Payer Report).
Stage IV cancer was significantly more common among multiuse participants than earlier
stage cancer (n = 112); the mean stage was 3.13 (median = 4, mode = 4). A chi-square analysis
was conducted to determine if the distribution of cancer stages was meaningful or likely due
chance compared to demographics of all new cancer cases at PRCP. Results from the chi-square
analysis suggested the distribution of cancer stages among multiuse participants was not due to
chance (X2(3) = 149.90, p < 0.05). As speculated, multiuse participants with stage IV cancer were
represented more frequently than statistically expected. Despite comprising 19.7% of PRCP’s
entire patient population, stage IV cancer patients represented 52.8% of all multiuse participants.
Alternately, participants with stage I cancer were significantly underrepresented. Stage I cancer
patients comprised the majority of PRCP’s patient population (n = 29.5%), but only comprised
11.3% of multiuse participants.
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Figure 10. Distribution of cancer stage: multiuse participants.
Table 10
Chi-Square Analysis: Cancer Stage Among Multiuse Participants

Stage I
Stage II
Stage III
Stage IV

(O) Observed
Frequency

(E) Expected
Frequency

(D) Difference

(O-E)2

(O-E)2/E

24
38
32
112

61
35
25
41

-37
3
7
71

1,352
8
44
5,101

22.25
0.22
1.75
125.68

The average number of visits or points of contact with PSS staff was 7.98 for multiuse
participants (median = 4, mode = 2). An analysis of the frequency of contact with PSS based on
participants’ stage cancer illustrated that participants with advanced stage cancer were
significantly more likely to have more frequent interaction with PSS than participants with earlystage cancer.
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Figure 11. Distribution of cancer stage and contact with PSS: multiuse participants.
Beyond phone contact and distress assessment, multiuse participants utilized a range of
program services. Participants were most likely to have interaction with staff at an office visit
(n = 82) or during infusion treatment (n = 81). Of note, 42% of the multiuse participants
involved family members in their care (n = 88). Multiuse participants also utilized nutrition
services (n = 69) and the Cancer Resource Center (n = 60) on a fairly consistent basis; however,
financial services were less likely to be utilized (n = 34).
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Figure 12. Distribution of program services: multiuse program participants.
Group program participants. Ninety-nine participants attended a support group on at
least once occasion. Fifteen percent of group participants were male, while 85% were female. In
general, group users were more likely to represent a younger patient population. The majority of
group participants were between the ages 55–64 (n = 32%) and the mean age was 57.7
(median = 57, mode = 52). Group users were most reflective of patients under the age of 45
(n = 11%) compared to other participant groups and 29% of group participants were ages 45–54.
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Table 11
Percentage Rates and Frequency of Demographics: Group Participants
Percentage

Frequency

Gender
Male
Female

15.2%
84.8%

15
84

Participants Age
26 to 34
35 to 44
45 to 54
55 to 64
65 to 74
75 or older

2.0%
9.1%
29.3%
32.3%
20.2%
7.1%

2
9
29
32
20
7

While support groups presumably had the opportunity to reach a vast and broad
population, the majority of group participants represented women diagnosed with breast cancer
(n = 64). The fact that women with breast cancer dominated all other group participants was
likely a result of the current content of support groups offered at PRCP. At the time of this
evaluation, two of the six support groups facilitated at by PSS staff were exclusive to women
diagnosed with breast cancer, clearly affecting group membership and representation. The
remaining 35 participants represented a diverse set of cancers, though many cancers were
underrepresented among group users. Lung and blood cancers were especially underrepresented
compared to their prevalence among PRCP’s general patient population. Results from a chisquare analysis confirmed the uneven distribution of cancer types among group members when
compared to PRCP’s patient population (X2(10) = 116.67, p < 0.05).
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Figure 13. Distribution of cancer type: group participants.
Table 12
Chi-Square Analysis: Cancer Type Among Group Participants
(O) Observed
Frequency

(E) Expected
Frequency*

(D) Difference

(O-E)2

(O-E)2/E

Glioblastoma
2
2
0
0
0
Head & Neck
4
6
2
5
0.86
Lung
6
14
8
68
4.78
Breast
64
19
-45
2,007
104.47
Liver
1
1
0
0
0
Pancreas
1
2
1
1
1
Kidney
1
3
2
4
1.22
Colorectal
5
8
3
8
1.02
Female
7
9
2
5
0.53
Reproductive
Male
4
6
2
5
0.86
Reproductive
Blood
4
9
5
20
2.39
Note. Expected frequencies were calculated based on observed frequencies of cancer type among
all new cancer cases at PRCP at the time this evaluation was conducted (see Appendix F for a
full report, PRCP Incidence of Cancer by Site and Primary Payer Report).
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Contrary to multiuse participants, stage I cancer was more common among group
participants than later stages of cancer (n = 33). The mean stage for group users was 2.16
(median = 2, mode = 1). A chi-square analysis was conducted to determine if the distribution of
cancer stages was meaningful or likely due chance compared to demographics of all new cancer
cases. Results from the chi-square analysis suggested the distribution of cancer stages among
group participants was, in fact, equal to chance and reflective of PRCP’s general patient
population (X2(3) = 7.84).
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Figure 14. Distribution of cancer stage: group participants.
Table 13
Chi-Square Analysis: Cancer Stage Among Group Participants

Stage I
Stage II
Stage III
Stage IV

(O) Observed
Frequency

(E) Expected
Frequency

(D) Difference

(O-E)2

(O-E)2/E

33
20
19
20

27
16
11
18

6
4
8
2

34
18
59
4

1.27
1.58
5.22
0.19
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Figure 15 reflects the frequency of contact group participants had with PSS based on their
stage cancer; contact frequency did not include the number of support groups attended by
participants, only that a participant attended a support group and whether or not additional
program services were used. The average number of visits or points of contact with PSS staff
(not including number of support groups attended) was 10.37, suggesting that group participants
use program services more frequently than other participants. Participants with early-stage
cancer were more likely to only attend a support group and utilized fewer follow up visits than
participants with cancer stages II–IV. Participants with later stage cancer (II–IV) appeared to
utilize services fairly homogenously, demonstrating, again, the likelihood that the demographics
of participants who attended groups was due to chance rather than representative of a meaningful
difference.
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Figure 15. Distribution of cancer stage and contact with PSS: group participants.
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Beyond phone contact and distress assessment, group participants were most likely to
attend an office visit with PSS staff (n = 51). Of note, more than a third of group participants
included family members in their care (n = 37), which may in part be attributed to support group
options available to family members and caregivers. Group participants were more likely to
utilize the Cancer Resource Center (n = 35), than receive support during infusion (n = 26).
Nutrition and financial services were less likely to be utilized.
Distribution of Services
Group
57

51

46

37

35
26

22
9

Figure 16. Distribution of program services: group participants.
Six support groups were offered to participants during the twelve months prior to this
evaluation: general support (previously its own group, but now incorporative of the advanced
cancer and caregiver support groups), tai chi, breast cancer, young women with breast cancer, art
therapy, and survivorship. Figure 17 illustrates the number of new patients or family members
that attended each support group on at least one occasion in the twelve months prior to this
evaluation, as indicated by group sign in sheets. Aside from the survivorship group, support
groups were similarly attended by participants, which included family members and patients of
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other cancer facilities. The most frequently attended groups were tai chi (n = 41) and art therapy
(n = 41). The third most frequently attended group was the general support group (n = 34). Of
note, tai chi, art therapy, and the general support group were open to family members and
caregivers of patients, which likely contributed to their more robust attendance numbers. The
two breast cancer support groups were limited to patients or survivors of breast cancer. The
survivorship support group was the only closed group offered at PRCP, requiring preregistration
and occurring on a more limited basis, reflecting it’s smaller attendance numbers.
Distribution of Support Groups
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Figure 17. Distribution of support groups: group participants.
Comparison of program services between group categories. After reviewing patient
demographics for single-use, multiuse, and group participants separately, data was again
aggregated to compare how program services were utilized between the three participant groups.
Multiuse and group participants were most likely to represent patients 55–64 years old,
whereas single-use participants were most likely to represent patients over the age of 65. Singleuse participants were especially representative of patients older than 75, compared to multiuse
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and group participants. Group participants were observed in high numbers among patients age
45–54 compared to single and multiuse participants. Patients under the age of 44 were
represented across all three groups nearly equally, with patients age 35–44 represented more
frequently observed in groups than among single or multi-service users.
Comparison Between Groups
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Figure 18. Comparison between groups: age range.
Figure 19 illustrates how PSS services were utilized by age range. Aside from telephone
contact and distress assessments which should capture most of all patients based on NCCN
(2016b) psychosocial screening guidelines, several program services stand out among
participants, regardless of age. Infusion, office visits, support groups, and family counseling
were well utilized by all participants to a large degree, regardless of age. Financial support, the
Cancer Resource Center, and nutrition services appeared to be less well utilized than counseling
services.
Participants 55–64 years old were most frequently and consistently represented across
all program services, followed by participants ages 45–54. Participants under the age of 35 were
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consistently underrepresented across all program services, which was indicative of lower cancer
incidence rates of younger persons in general (Cancer Research UK, 2016) and PRCP’s patient
population at-large. Participants over the age of 75 were less likely to engage in program services
beyond distress assessment; however, elderly participants did commonly involve family
members in their care, respective of their overall participation in program services.
Distribution of Program Services & Age Range
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Figure 19. Distribution of program services: age range.
Women were more frequently represented in higher numbers across all three groups,
representing 68% of all participants (n = 271). Men and women were most evenly distributed
among single-use participants, which was likely due to the fact that all patients receive at least an
initial, one-time screening with PSS staff whereas group and multiuse participants represented
patients seeking follow up care beyond an initial screening. It appeared that, in general, men
were much less likely to seek services beyond an initial screening.
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Comparison Between Groups: Gender
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Figure 20. Comparison between groups: gender.
Women were consistently represented in higher numbers across all program services.
Women were least likely to utilize financial services, representing fewer than 11% of all female
participants. Women were consistently represented among the Cancer Resource Center, infusion,
office visits, family counseling, and support groups, with the highest percentage of women
attending an office visit (n = 35%).
Men appeared less likely to utilize supplemental supportive services, such as the Cancer
Resource Center or financial support. Men were also poorly represented among support groups,
although the current data did not include information from the men’s only support group for
prostate cancer because PSS staff did not facilitate that group. Forty-four percent of men did,
however, include family members in their care and 35% of men attended an office visit with
staff. Support during infusion and nutrition services were utilized by 27–29% of male
participants, respectively.
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Distribution of Program Services & Gender
Male

Female

188
121
89

82

47
13

37

95

75

54
14

29

35

45

57

84

83
15

Figure 21. Distribution of program services: gender.
Participation in program services appeared to vary based on participants’ primary health
insurance coverage. In general, participants with Medicaid were more likely to participate in
nearly all program services, despite comprising only 16% of all participants. Especially
noteworthy, participants with Medicaid were three times as likely to utilize financial services
(n = 27%) compared to Medicare (n = 9%) and commercial insurance users (n = 5%).
Commercial and Medicare participants appeared nearly unequivocal across all program
services, aside from distress assessment and support groups. Medicare participants were more
likely to receive follow up on distress assessments while participants with commercial insurance
were nearly twice as likely (36%) to participate in support groups than either Medicare
(n = 16%) or Medicaid (n = 17%) participants.
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Figure 22. Distribution of program services: primary insurance.
Figure 23 illustrates how cancer diagnoses varied among service user groups. As
previously discussed, breast cancer patients represented the majority of PRCP’s patient
population at-large. As such, breast cancer patients were more frequently represented across all
three groups by a significant amount, nearly one and a half times the frequency of all other single
and multiuse participants and nearly ten times the frequency of all other group participants.
Further, breast cancer patients were nearly three times as likely to attend a support group than to
represent single or multi-use participants.
Because breast cancer patients dominated the representation of group program users,
differences could be seen among group users and single/multiuse participants across cancer type.
For example, lung cancer patients were three times as likely to represent multiuse participants
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(n = 18) than group participants (n = 6). Likewise, patients with blood cancer were also three
times as likely to represent multiuse participants (n = 13) than group participants (n = 4). Head
and neck cancer patients were more than two times as likely to represent multiuse participants
(n = 11) than single-use and group participants (n = 4). In a few instances, single-use
participants outnumbered multiuse and group participants, as was the case with colorectal and
male reproductive cancer patients. Interestingly, patients with female reproductive cancers were
represented nearly homogenously across participant groups.
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Figure 23. Comparison between groups: cancer type.
Figure 24 reflects how program services were utilized across common cancer diagnoses.
Breast cancer was superiorly represented across all program services, which corresponds with
high prevalence rates (N = 12.3%) observed nationally (National Cancer Institute, 2016) and
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among PRCP’s patient population (n = 22.6%). Participants with breast cancer were most well
represented in support groups (n = 64) in addition to office visits (n = 52). Interestingly, despite
similarly high prevalence rates for prostate cancer (N = 14%), participants with male
reproductive cancers were consistently represented in low numbers across program services and
within PRCP in general. Of the male reproductive cancer patients that did utilize program
services, participants were most likely to involve family members in their care (n = 9) and least
likely to utilize financial services (n = 0).
Lung cancer, which represents 13.3% of all new expected cancers nationally, was the
second most commonly occurring cancer at PRCP and, similarly, the second most prominent
cancer represented across program services unanimously. Participants with lung cancer were
especially well represented among family counseling services (n = 22) and less likely to utilize
financial services (n = 4) or support groups (n = 5).
Participants with head and neck, colorectal, female reproductive, and blood cancer were
closely represented across program services. Notably, participants with head and neck cancer
were most likely to utilize nutrition services (n = 21), which was likely due to adverse effects
from treatment commonly associated with head and neck cancer patients (National Cancer
Institute, 2013).
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Figure 24. Distribution of program services: cancer type.
As previously demonstrated in Figures 6 and 9, patients with stage IV cancer were most
well represented among single and multiuse participants, with the highest percentage of stage IV
patients representing multi service users (n = 53%). Alternately, stage I patients were most likely
to represent group participants.
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Figure 25. Comparison between groups: cancer stage.
Patients with stage IV cancer were represented more frequently than earlier stage cancer
across all program services, with the exception of support groups. Patients with stage IV cancer
were nearly three times as likely to involve family members in their care and two times as likely
to attend an office visit, receive services during infusion, and participate in nutrition services.
Alternately, patients with stage I cancer were represented less frequently across all program
services, with the exception of support groups in which case patients with stage I cancer were
most commonly observed (n = 33). Patients participated in the Cancer Resource Center nearly
equally, while financial services were most frequently utilized by patients with cancer stage II
and later.
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Figure 26. Distribution of program services: cancer stage.
Patients receiving chemotherapy were represented in high numbers across most program
services, which could be expected given the near ubiquity of chemotherapy in treating cancer
systemically (Cancer Research UK, 2015). Interestingly, patients who received chemotherapy
alone were most likely to attend an office visit (n = 35) and involve family members in their care
(n = 39), even more so than patients receiving chemotherapy in addition to surgery and/or
radiation. Patients receiving radiation alone were also more likely to involve family members
than patients receiving multiple treatments (n = 31).
Of note, patients receiving multiple treatments (surgery + chemotherapy, surgery +
chemotherapy + radiation) were nearly twice as likely to attend a support group than patients
receiving surgery, chemotherapy, or radiation alone. Patients receiving multiple treatments were
also more likely to use the Cancer Resource Center than patients receiving single modality
treatments. Financial services were utilized fairly evenly among participants, though patients
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receiving radiation or surgery combined with chemotherapy were less likely to use financial
services than others.
Differences in how program services were utilized may be, in part, attributed to how
program referrals were made within each department, as distinct departments govern surgery,
chemotherapy, and radiation and referrals were likely handled differently between each
department. Additionally, differences in program participation may have been indicative of how
patients’ needs and their ability to utilize program services fluctuated as they moved throughout
the treatment process.
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Figure 27. Distribution of program services: cancer treatment.
Satisfaction of Services
Two surveys were created and distributed to patients and PRCP staff to solicit feedback
and opinions about their experiences using PSS program services. Patients and PRCP staff were
asked to respond to a series of statements indicating their level of agreement or disagreement.
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Statements inquired about patients’ familiarity with the department and program services,
utilization of services, satisfaction with the quality and variety of program services and PSS
staffing, opinions about the impact program services had as part of their cancer care treatment,
and perceived strengths and areas for improvement. Similarly, PRCP staff were asked about their
familiarity with the department and program services, the referral process (how often, which
services, and under what circumstances program services were recommended), opinions about
the importance or value including behavioral health services in a cancer treatment program, and
perceived strengths and areas for improvement. Results from surveys were used to identify
trends and inform program recommendations based on perceived strength and areas of
improvement.
Patient satisfaction. In total, 590 surveys were made available for distribution to
patients by mail (n = 440) and in person (n = 150). One hundred and fifty-two patient surveys
were returned, accounting for a 26% return rate. Seventy-nine surveys were returned by mail, 49
surveys were returned to reception following office visits with an oncologist, 18 surveys were
returned to American Cancer Society volunteers during chemotherapy infusion, and six surveys
were returned to PSS staff following a support group meeting.
Patient demographics. Demographic information was collected to describe the patient
population who participated in providing program feedback. Of the 152 returned surveys, 142
surveys were completed by patients and nine were completed by family members or caregivers.
The majority of respondents were between the ages 65–74 (n = 56). Fewest responses were
received from persons under the age of 45 (n = 7).
Sixty-two percent of respondents identified as female and 38% identified as male. The
majority of respondents identified as married or in a domestic partnership (n = 89), while 41%
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identified as single (n = 17), separated (n = 3), divorced (n = 18), or widowed (n = 14). Ninetyone percent of respondents identified as Caucasian or White American while 9% identified as
persons of color.
Table 14
Percentage Rates and Frequency of Patient Demographics
Percentage

Frequency

Gender
Male
Female

38.0%
62.0%

57
93

Respondents Age**
26 to 34
35 to 44
45 to 54
55 to 64
65 to 74
75 or older

2.0%
2.7%
15.4%
21.5%
37.6%
20.8%

3
4
23
32
56
31

Relationship Status*
Single
Married or Domestic Partner
Separated
Divorced
Widowed

11.3%
59.3%
2.0%
18.0%
9.3%

17
89
3
27
14

*

Race/Ethnicity**
Caucasian/White
90.7%
136
Hispanic/Latino
2.0%
3
African American/Black
0.7%
1
Asian/Pacific Islander
4.7%
7
American Indian/Alaska Native
2.0%
3
Note. *Based on 150 responses; two blank responses. **Based on 149 responses; three blank
responses.
Cancer and treatment. Patient demographics were widely represented according to type
and stage of cancer, the year treatment began, and types of treatment completed in the past
twelve months. The majority of patients began treatment between 2014–2015 (n = 97); 24
patients began treatment between 2010–2013. Two patients began treatment prior to 2007, the
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year PRCP was established as an integrative oncology center. Twenty-eight respondents did not
report the year treatment began.
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Figure 28. Patient demographics: year treatment began.
Among survey respondents, the three most frequently reported types of cancer were
breast cancer (n = 52), blood cancer (n = 21), and male reproductive cancer (n = 19),
representing 62% of all respondents. Female reproductive cancers and lung cancer were equally
represented as the 4th and 5th most commonly occurring cancers among survey respondents,
comprising 22% of all respondents.
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Table 15
Percentage Rates and Frequency of Primary Cancer

What Type of Cancer is Being Treated?
Bladder cancer
Blood cancer
Bone cancer
Brain tumor
Breast cancer
Colorectal cancer
Female reproductive cancer
Head and neck cancer
Kidney cancer
Liver cancer
Lung cancer
Male reproductive cancer
Myelodysplastic syndrome
Pancreatic cancer
Skin cancer
Soft tissue sarcoma
Note. Based on 148 responses; four blank responses.

Percentage

Frequency

1.4%
14.2%
3.4%
3.4%
35.1%
7.4%
10.8%
7.4%
0.7%
2.7%
10.8%
12.8%
0.7%
1.4%
2.0%
1.4%

2
21
5
5
52
11
16
11
1
4
16
19
1
2
3
2

The demographics of survey respondents were compared to PRCP’s population at-large.
As evidenced in Figure 29, demographics of survey respondents were generally representative of
PRCP’s population at-large. Interestingly, the three most reported cancer types—breast, blood
cancer, and male reproductive cancers—were overrepresented in the survey sample compared to
PRCP’s general population. Alternately, lung and bladder cancers appeared to be
underrepresented in the survey sample compared to PRCP’s population.
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Figure 29. Comparison between PRCP population and survey respondents: cancer type.
A large percentage of respondents were unable to identify their stage of cancer (n = 50).
Of those able and willing to report their stage of cancer, 28% of respondents identified as having
stage IV disease, while only 14% of respondents reported stage I disease. Stages II and III cancer
accounted for 27% of all respondents.
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Figure 30. Patient demographics: cancer stage.
The demographics of survey respondents were compared to PRCP’s population at-large.
While PRCP’s general population revealed predominate occurrences of patients with stage I
cancer, survey respondents were much more likely to represent patients with stage IV cancer.
Indeed, stage I cancer was underrepresented by survey respondents, while stage IV was
overrepresented compared to PRCP’s general population.
Interestingly, this trend was evident among utilization results as well, as indicated in the
above sections. Among patients who participated in program services (i.e., utilization of services
results) and surveys (i.e., satisfaction of services results), stage IV patients were predominately
represented. This finding suggested patients with stage IV cancer were most likely to participate
in program services (i.e., multiuse program participants) and most likely to respond to
questionnaires about their satisfaction with program services. Patients with stage IV cancer may
have been more likely to participate in the satisfaction survey based on their familiarity and use
of program services, as previously indicated based on trends in utilization of services.

83

Observed Frequencies

Comparison Between PRCP Population & Survey Respondents
45%
40%
35%
30%
25%
20%
15%
10%
5%
0%

PRCP
Survey Respondents

Stage 0 Stage I Stage II Stage III Stage IV
Cancer Stage

Figure 31. Comparison between PRCP population and survey respondents: cancer stage.
Respondents were well represented across the most common types of cancer treatment
including biopsy (n = 74), surgery (n = 62), chemotherapy (n = 96), and radiation therapy
(n = 82). Less commonly occurring treatments included hormone therapy (n = 21), clinical
research trials (n = 5), palliative care (n = 2), and hospice care (n = 1). Lastly, seven respondents
reported being under observation but not actively receiving treatment.
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Treatment Modalities Received in the Past 12 Months
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Figure 32. Treatment modalities.
Familiarity and use of program services. Forty-two percent of respondents indicated
they were well informed about services available through Patient Support. An additional 40% of
respondents indicated having knowledge of program services and being aware of where to go for
more information as needed. Eighteen percent of respondents indicated needing more
information (n = 13) or having no information at all (n = 13).
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Figure 33. Familiarity of program services.
Forty-nine percent of respondents indicated using program services at one point while
receiving treatment at PRCP. Of those respondents, 71 indicated which services or combination
of services they used: Thirty-nine percent attended a support group, 37% utilized social work,
resources, or financial assistance, 30% participated in counseling with a staff member, and 27%
received emotional support from staff directly during treatment. Patients also indicated using
nutrition services and attending supportive services offered through the Cancer Resource Center,
including the Look Good, Feel Better class which was hosted by the American Cancer Society.
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Table 16
Percentage Rates and Frequency of Patient Support Services Used

Have You Used Program Services?
Yes
No

Percentage

Frequency

48.6%
51.4%

72
76

*

Which Services Have You Used? Select All That
Apply**
Emotional support during treatment
26.8%
19
Counseling with PSS staff
29.6%
21
Attending a support group
39.4%
28
Social work, resources, financial assistance
36.6%
26
Note. * Based on 148 responses; four blank responses. ** Based on 71 responses; 81 blank
responses.
The 71 patients who reported using services during their treatment were characterized
as follows: Seventy-one percent were female and 56% were between the ages 55–74. Breast
cancer was the most commonly occurring cancer by far (n = 42%), while the stage of cancer was
nearly equally represented between stages I–IV, with stage IV cancer reported most frequently
(n = 25%).
Of note, the demographics of patients who reported using services on surveys were
largely similar to the demographics of patients who used services according to results from the
utilization of services results. Indeed, survey results appeared to corroborate the general
characteristics of patients who participated in program services. Results from utilization of
services and surveys suggested the most common characteristics of patients who use services
were women, persons between the ages 55–75, patients with breast cancer, and stage IV cancer
patients.
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Table 17
Percentage Rates and Frequency of Demographics of Patients Who Used Services
Percentage

Frequency

Gender
Male
Female

29.2%
70.8%

21
51

Respondents Age
26 to 34
35 to 44
45 to 54
55 to 64
65 to 74
75 or older

2.9%
5.7%
21.4%
24.3%
31.4%
14.3%

2
4
15
17
22
10

What Type of Cancer is Being Treated?
Bladder cancer
Blood cancer
Bone cancer
Brain tumor
Breast cancer
Colorectal cancer
Female reproductive cancer
Head and neck cancer
Kidney cancer
Liver cancer
Lung cancer
Male reproductive cancer
Skin cancer
Soft tissue sarcoma

1.4%
16.9%
2.8%
4.2%
42.3%
5.6%
16.9%
5.6%
1.4%
1.4%
9.9%
4.2%
1.4%
2.8%

1
12
2
3
30
4
12
4
1
1
7
3
1
2

What Stage of Cancer is Being Treated?
Stage 0
Stage I
Stage II
Stage III
Stage IV
Unknown

1.5%
15.9%
14.5%
18.8%
24.6%
24.6%

1
11
10
13
17
17

Satisfaction with program services. Program satisfaction results are reported separately
based on patients’ participation in program services during their treatment. Respondents who
reported using program services are referred to as “participants” while respondents who reported
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not using program services are referred to as “non-participants.” Program satisfaction was
defined by respondents’ opinions and experiences regarding the quality and variety of program
services as well as staffing accessibility and responsiveness.
Quality. Sixty-seven program participants responded to the survey question about
satisfaction regarding the quality of program services provided by PSS staff. Results
demonstrated high satisfaction with the quality of program services. Eighty-four percent of
participants reported being fully satisfied, while 10% reported being somewhat satisfied. Six
percent reported neutral feelings. None of the program participants reported dissatisfaction with
the quality of program services provided.
Twenty-two non-participants responded to the survey question about quality of program
services. Interestingly, 45% reported being fully satisfied. Fifty percent felt neutral about quality
of services, while one non-participant reported full dissatisfaction.
Satisfaction: Quality of Program Services
Participants

Non-Participants

56

10

11

7
0

Satisfied

Somewhat
Satisfied

4
Neutral

Figure 34. Patient satisfaction: quality of program services.
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Variety. Sixty-eight program participants responded to the survey question about
satisfaction regarding the variety of program services provided by PSS staff. Program variety
also received high reviews based on participants’ responses. Seventy-eight percent of program
participants reported full satisfaction with the variety of programs services provided by staff.
Nine percent reported being somewhat satisfied, while 12% reported feeling neutral. One
participant reported being somewhat dissatisfied with the variety of program services offered.
Twenty-four non-participants responded to the survey question about variety of
program services. Fifty-four percent reported being fully satisfied with the variety of program
services. Forty-two percent felt neutral, while one non-participant reported full dissatisfaction.
Satisfaction: Variety of Program Services
Participants

Non-Participants

53

13

8

6

10
1

0
Satisfied

Somewhat
Satisfied

Neutral

0

Somewhat
Dissatisfied

0

1

Dissatisfied

Figure 35. Patient satisfaction: variety of program services.
Staffing. Sixty-eight program participants responded to the survey question about their
satisfaction with program staff. Overall, participants responded favorably regarding the
accessibility and responsiveness of staff. Seventy-nine percent reported being fully satisfied.
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Seven percent reported being somewhat satisfied and 13% reported neutral feelings. None of the
program participants reported dissatisfaction regarding staff access and responsiveness.
Twenty-two non-participants responded to the survey question about staffing.
Consistent with non-participants views of satisfaction with program quality and variety, 45%
reported being fully satisfied with staff access and responsiveness. Nine percent reported being
somewhat satisfied, while forty-one percent felt neutral. One non-participant reported full
dissatisfaction.
Satisfaction: Staff Access & Responsiveness
Participants

Non-Participants

54

10

Satisfied

5

9

9

2

Somewhat
Satisfied

0
Neutral

0

Somewhat
Dissatisfied

0

1
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Figure 36. Patient satisfaction: staff access and responsiveness.
Overall value of program services. In general, respondents indicated they considered
PSS a valuable part of their cancer treatment at PRCP. Fifty-seven percent of all respondents
reported strong agreement, while 20% reported agreement. Nineteen percent of all respondents
reported neutrality, of which thirteen respondents were non-participants and seven were program
participants. Five percent of all respondents indicated strong disagreement regarding their
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perceived value of program services; of those respondents, four were non-participants and one
was a program participant.
Value of Program Services
Participants

Non-Participants

46

15

15

13
6

7
0

Strongly Agree

Agree

Neutral

0

Disagree

1

4

Strongly
Disagree

Figure 37. Patient satisfaction: value of program services.
Not surprisingly, the likelihood of respondents using program services or recommending
program services to other patients and family members varied based on respondents participation
in program services. Forty-one percent of all respondents reported a high likelihood of
continuing to use program services or using them in the future. An additional 18% of all
respondents reported being somewhat likely to participate in services, while 20% reported
neutrality. Of the respondents who reported disagreement, 38% of non-participants reported
being unlikely to use program services, while 9% of program participants reported being unlikely
to continue using services.
Program participants were highly likely to recommend services to others (n = 80%),
reporting minimal ambivalence (n = 8%) and no dissonance. Although non-participants

92
accounted for a smaller representative sample, overall they were less likely to recommend
services (n = 45%) and more likely to report ambivalence (n = 10%) or dissonance (n = 21%).
Likelihood of Using or Continuing to Use Serices
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Non-Participants
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Figure 38. Patient satisfaction: likelihood of using or continuing to use program services.
Likelihood of Recommending Program Services
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Figure 39. Patient satisfaction: likelihood of recommending program services.
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Areas of strength. Areas of perceived strength are reported in aggregate form based on
responses from both participants (n = 60) and non-participants (n = 12). Respondents were
offered three program service choices (emotional support, support groups, resources and
financial support) and asked to select the program service they viewed most helpful, though
many respondents chose more than one service. Fifty percent of all respondents reported
emotional support was the most helpful service provided. Support groups were viewed as most
helpful by 34% of respondents, while 32% of respondents indicated access to resources and
financial support was most helpful. Respondents indicated three other noteworthy support
services not listed including nutrition (n = 1), naturopathic medicine (n = 1), and American
Cancer Society volunteers (n = 4).

Which Services Have Been Most Helpful?
38

40
35
30

26

25

24

20
15
10

6

5
0
Emotional Support

Support Groups

Resources &
Financial

Other

Figure 40. Patient satisfaction: areas of strength.
Areas of improvement. Respondents were asked to provide open-ended feedback about
perceived areas of improvement. Thirty-eight respondents provided feedback. Interestingly, 21
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respondents used this question as a platform to express gratitude or their overall satisfaction with
support services. Specific critical feedback was provided by 16 respondents and categorized into
three themes: (a) education and outreach, (b) services and access, and (c) PSS staffing.
Education and outreach. Several respondents recommended spending more time
educating and informing patients and staff about PSS and support options. One respondent asked
for greater emphasis on integrated services.
Several respondents wanted more emphasis providing patient outreach and education
near the beginning of treatment. One respondent recommended holding a monthly information
session for new patients and family members to learn about support service options. Another
respondent requested more information advertising support group options and availability or
meeting times. A third respondent wanted medical providers to offer “stronger encouragement”
to patients to use support services.
Services and access. Respondents recommended several areas of interest related to
available support service options. Areas of improvement included transportation services,
transitioning to hospice care, and family and caregiver support opportunities. One respondent
asked for more support services specifically for breast cancer. In addition, a request was made to
offer support group options more frequently (i.e., weekly) as well as making weekend support
available for patients.
PSS staffing. Staffing concerns were less likely to be identified as an area of
improvement; however, two respondents indicated frustration with the lack of training/education
or consistency among support staff persons. Another respondent expressed disappointment with
the department not being “sufficient,” though more specific information was not provided.
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Staff satisfaction. In total, 110 staff were invited to participate in a survey including:
medical and radiation oncologists (n = 11), advanced care practitioners (n = 4), nurses (n = 31),
medical assistants (n = 11), other clinical staff (n = 16), nonclinical support staff (n = 15), and
administrators (n = 22). Other clinical staff included clinical nurse specialist, palliative care,
nutrition, pharmacy, phlebotomy, and radiation therapy technology. Nonclinical support staff
included financial counseling, patient navigation, clinical research, radiation physics, medical
dosimetry, nuclear medication technology and information technology. The administration team
consisted of receptionists, schedulers, health information services, administration assistants, and
administration management. Forty-one staff completed the survey, accounting for a higher than
average return rate of 37%.
Staff demographics. Of the 41 surveys returned, the nursing team provided the most
responses with 42% of nursing staff participating. Four physicians and two medical assistants
responded accounting for 15% of the total responses; however, physicians and medical assistants
represented a fairly low response rate given the size of their departments (36% and 18% response
rate, respectively). Advanced care practitioners did not participate in the survey, which may be
related to concerns regarding anonymity given their small numbers among all staff (n = 4).
Conversely, a high percentage of support persons participated representing 73% support staff
persons, 31% clinical staff persons, and 22% of administrative staff persons.

96
Table 18
Staff Demographics: Employment Position

Employment Position
Physician
Advanced Care Practitioner
Nurse
Medical Assistant
Other Clinical Staff
Support Staff
Administration
Anonymous
Total

Invited

Responded

Response Rate

11
4
31
11
16
15
22
n/a
110

4
0
13
2
5
11
5
1
41

36.4%
0%
41.9%
18.2%
31.3%
73.3%
22.7%
n/a

Staff who responded to the survey most frequently were also those staff members
employed at PRCP the longest, serving 7–8 years (n = 18). Staff members least likely to respond
were those employed less than one year (n = 3) as well as those employed 3–4 years (n = 3).

Years Employed
<1
7%

1-2
20%

45%

8%
20%

Figure 41. Staff demographics: number of years employed at PRCP.

3-4
5-6
7-8
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Familiarity with program services. Sixty-eight percent of respondents indicated they
were familiar or very familiar with services offered by PSS. Two percent indicated they were not
familiar with PSS at all, while 29% reported some familiarity.
Table 19
Percentage Rates and Frequency of Patient Support Services Familiarity
Percentage

Frequency

How Familiar Are You With Services Offered?
(1) Very familiar
43.9%
18
(4) Familiar
24.4%
10
(3) Somewhat familiar
24.4%
10
(2) A little familiar
4.9%
2
(1) Not at all
2.4%
1
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar
with services.
Referrals to program services. Despite a high percentage of respondents indicating their
familiarity with PSS, fewer than half the respondents reported frequent referrals. Thirty-six
percent of respondents reported referring to PSS often to very often. Ten percent of respondents
indicated they did not refer to PSS at all, while 45% of respondents reported sometimes referring
to PSS. It is worth noting, these findings did not account for staff positions and whether low
referrals represented staff with minimal patient interaction or clinical providers. It is likely that
low referrals were, in part, attributed to nonclinical staff positions rather than poor familiarity
with program services, since PRCP indicated good familiarity with PSS in the above survey
question.
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Table 20
Percentage Rates and Frequency of Patient Support Services Referrals
Percentage

Frequency

How Often Do You Refer to PSS?
(1) Very often
24.4%
10
(4) Often
12.2%
5
(3) Sometimes
39.0%
16
(2) Not very often
14.6%
6
(1) Not at all
9.8%
4
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar
with services.
PSS resources most frequently recommended to patients were social work (66%) and
counseling (61%). The Cancer Resource Center (59%), support groups (56%), nutrition (54%),
and financial resources (51%) were also highly recommended by staff. One respondent reported
referring patients for cognitive testing while another respondent commented “other,” reporting
transportation concerns as a referral reason. Six respondents noted they did not recommend PSS
to patients given their employment position.
Recommended Services
24

22

25
21

27
23

6
2

Figure 42. Staff satisfaction: recommended Patient Support Service resources.
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When asked about the circumstances or situations staff members typically referred
patients to PSS, respondents identified four scenarios most frequently: patients expressing
emotional distress (n = 70%), concern or support for family members (n = 66%), complex
medical and/or psychosocial concerns (n = 63%), and transportation concerns (n = 63%). Three
additional scenarios were identified with great frequency: concerns regarding risk of self-harm or
injury (n = 59%), financial stress (n = 54%), and nutrition concerns (n = 51%). Thirty-seven
percent of respondents said they referred patients to services when upsetting news was received
or delivered, while only 15% of respondents reported referring patients whose health has
declined. Twenty-seven percent of respondents reported referring to services when a patient
upset staff or other patients. Twenty-two percent of respondents reported referrals when concerns
about patients’ cognitive skills or comprehension were questioned, while only 15% of
respondents made referrals when patients had difficulty understanding their disease and
treatment options.
Several respondents also reported unique circumstances that preceded their referral to
PSS including, palliative care services (n =1), high levels of distress indicated on PRCP’s
Distress Assessment form (n =1), or when staff encountered a patient complaint or concern
(n =1). Fourteen percent of respondents (n = 6) indicated they did not refer patients to services
given their employment position.
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Table 21
Percentage Rates and Frequency of Referral Scenarios

What Types of Situations Do You Typically Refer
Patients to PSS? Select All That Apply:
When a patient appears upset or distraught
When a patient receives upsetting news
When family has concerns or needs support
When a patient has difficulty understanding
diagnosis, prognosis, or treatment options
When a patient appears cognitively impairment or
has difficulty comprehending
When a patient’s health begins to decline
When a patient has complex medical or psychosocial
needs
When a patient appears at risk of self-harm or injury
When a patient has upset staff or other patients
When a patient has financial concerns
When a patient has transportation concerns
When a patient would benefit from a nutrition
consultation
What a patient would benefit from additional time or
attention
Not applicable: I do not refer patients in my position
Other

Percentage

Frequency

70.7%
36.6%
65.9%
14.6%

29
15
27
6

22.0%

9

14.6%
63.4%

6
26

58.5%
26.8%
53.7%
63.4%
51.2%

24
11
22
26
21

41.5%

17

14.6%
7.3%

6
3

Overall value of program services. Eight-five percent of respondents indicated they very
much considered Patient Support Services a valuable part of PRCP’s cancer treatment program.
Ten percent of respondents stated that PSS services were moderately valuable, while two
respondents responded that services were only somewhat valuable. No respondents indicated a
lack of value regarding PSS.
Similarly, the majority of respondents stated PSS had a positive to very positive effect on
treatment outcomes for patients (n = 35). Twelve percent of respondents stated that services had
a somewhat positive effect on outcomes, while one respondent disagreed indicating that PSS had
little positive effect on outcomes.
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Table 22
Percentage Rates and Frequency of Patient Support Services Value
Percentage

Frequency

85.0%
10.0%
5.0%
0%
0%

34
4
2
0
0

*

Do You Consider PSS a Valuable Part of PRCP?
(1) Very much
(4) Moderately
(3) Somewhat
(2) A little
(1) Not really

Does PSS Positively Affect Treatment Outcomes?
(1) Very much
63.4%
26
(4) Moderately
22.0%
9
(3) Somewhat
12.2%
5
(2) A little
2.4%
1
(1) Not really
0%
0
Note. Based on a Likert-scale, where 5 is very familiar with services and 1 is not at all familiar
with services. * Based on 40 responses; one blank response.
Staff members were also asked to endorse the perceived benefits of including
psychosocial services as an integrative program within cancer treatment. Respondents were most
likely to agree that psychosocial services helped improve patients’ ability to cope with expected
distress associated with cancer treatment (n = 90%) and reduced the risk of developing more
severe emotional disorders (n = 88%). A high percentage of respondents also agreed that
psychosocial services helped improve the satisfaction of services available for cancer treatment
(n = 83%) and improved patient compliance with treatment and follow up care (n = 80%). Sixtyfive percent of respondents agreed that psychosocial services helped improve patients’ overall
health and functioning. Respondents were less likely to agree that psychosocial services helped
reduce the financial costs of the medical system (n = 50%), the use of unnecessary medical
services (n = 55%), or the workload for treatment providers or staff (n = 48%).
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Table 23
Percentage Rates and Frequency of Patient Support Services Perceived Benefits

What Outcomes May Be Likely Because of Patient
Involvement in PSS? Select All That Apply:
Reduced risk of severe emotional disorders
Improved ability to cope with expected distress
Improved overall health and functioning
Improved satisfaction with cancer care services
Increased treatment compliance and follow up
Reduced workload for providers and staff
Lower use of unnecessary medical services
Reduced financial costs to our medical system
Note. Based on 40 responses; one blank response.

Percentage

Frequency

87.5%
90.0%
65.0%
82.5%
80.0%
47.5%
55.0%
50.0%

35
36
26
33
32
19
22
20

Areas of strength. Eight-five percent of respondents were in agreement that the greatest
strength of PSS was the team’s ability to provide emotional support to patients and family
members. According to respondents, the team’s second greatest strength was its ability to
provide crisis intervention and risk assessment (n = 66%). The third area of strength identified
was PSS’s ability to assess psychosocial needs (n = 63%). Triaging patients with high acuity and
facilitating support groups were less frequently reported as department strengths (n = 56%). Two
respondents replied “other” and identified the program’s strengths as providing financial
assistance and transportation. Two additional respondents stated they were unfamiliar with
program strengths given their employment position.
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Table 24
Percentage Rates and Frequency of Patient Support Services Strengths

What Does the PSS Team Do Particularly Well?
Select All That Apply:
Assess psychosocial needs
Facilitate support groups
Provide emotional support to patients and family
Provide crisis intervention and risk assessment
Triage patients with high acuity or distress
Other

Percentage

Frequency

63.4%
56.1%
85.4%
65.9%
56.1%
9.8%

26
23
35
27
23
4

Areas of improvement. Respondents identified several areas for program improvement
with high consistency. The two greatest areas of concern identified by respondents were
accessibility of staff (n = 27) and responsiveness to urgent needs (n = 21). Respondents
commented about the importance of staff responding to urgent concerns more readily and being
available for personal referrals from staff. Of mention, respondents noted difficulty reaching staff
by phone during regular business hours and one respondent requested faster response time
following up with patients who report high levels of distress on Distress Assessment
questionnaires. One respondent also suggested increasing staff access on Fridays. Two
respondents recommended staff walk around the infusion center to make themselves more
available to patients; additionally, two respondents wanted to ensure all patients were being
followed by PSS staff and mentioned the importance of having an initial meeting with PSS staff
as part of treatment orientation. Three respondents made requests for additional staff, including
first floor reception staff to help with patient check-in for psychosocial services and more fulltime employees in PSS including a full-time nutritionist/dietician and full-time social worker.
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The third most frequently identified area of concern was the diversity of support service
options (n = 12). Two respondents made specific requests for more options being made available
for caregivers or family members of patients.
Increasing publicity or marketing to recruit patients was identified with similar frequency
(n = 11). One respondent recommended business cards being made more readily available for
distribution, while another respondent requested better staff education regarding program
services, making referrals, and how to contact staff.
Respondents were least likely to identify revenue or funding opportunities as an area in
need of improvement (n = 5) or modifying the frequency of support group meetings (n = 7).
Three respondents did not recommend any areas for improvement while six respondents stated
they were unsure of areas in need of improvement.
Table 25
Percentage Rates and Frequency of Areas for Program Improvement

What Can PSS Do To Improve Its Services? Select All
That Apply:
Increase staff access during business hours
Improve staff response time for urgent needs
Offer support groups more frequently
Offer more support service options
Generate revenue or funding opportunities
Improve publicity or marketing to recruit patients
from the community
Nothing! Keep doing what you are doing!
I’m not sure
Other

Percentage

Frequency

65.9%
51.2%
17.1%
29.3%
12.2%
26.8%

27
21
7
12
5
11

7.3%
14.6%
17.1%

3
6
7

105
Chapter IV: Discussion
This evaluation examined Patient Support Services to determine what aspects of the
program were working well and what areas needed improvement. Evaluation findings provided
an overview of program services as they were currently utilized and valued by patients and staff.
The culmination of this evaluation presented stakeholders with informed recommendations to
improve program services based on identified areas of satisfaction and dissatisfaction. Evaluation
findings were presented to stakeholders on multiple occasions to collaboratively discuss program
strengths and areas for improvement. Recommendations were generated with input from PSS
staff and offered to stakeholders and program administrators to make informed decisions about
desired future program changes. An executive report was provided outlining evaluation findings
and recommendations for consideration (see Appendix R).
The following sections provide an overview of program strengths, areas identified for
improvement, program recommendations, and limitations of this evaluation.
Program Strengths
Many areas of strength were identified during the program evaluation. Indeed, the value
and worth of Patient Support Services was clearly demonstrated from the perspective of program
utilization as well as program satisfaction. Program strengths provide insight into services that
were well utilized and most valued; areas of strength should continue to receive attention from
PSS staff as program recommendations are considered.
Utilization of services. An analysis of program services was conducted to better
understand how program services were utilized and by whom, identifying program services that
were well utilized or well represented by patients. In general, an analysis of utilization of
services demonstrated alignment with the overall mission of PSS: To reach a broad patient
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population and provide services to some of PRCP’s patients in greatest need. Three areas of
strength were identified:
•

While this evaluation was not an exhaustive analysis of services utilized by all
patients but a snapshot of services provided during a specific timeframe, it did
demonstrate that more than 17% of all new patients at PRCP participated in
program services beyond Distress Assessments. While all patients are assessed for
low, moderate, and high levels of distress based on NCCN (2016b) guidelines, 330
of 1,904 all new patients participated in at least one program service beyond
Distress Assessment. Further, 83% of patients who utilized program services (n =
330 of 400) interacted with PSS beyond Distress Assessment. These findings
suggest that PSS reaches an expansive population of patients beyond screening
requirements as outlined by NCCN.

•

Participation in program services appeared to be reflective of patients’ needs and
presumed financial resources according to primary payer information. In general,
patients presumed to have the fewest financial resources participated in program
services more frequently and diversely, compared to patients presumed to have
better access to financial resources and support opportunities. Medicaid patients
were more likely to participate in nearly all program services, despite comprising
only 16% of program participants and 7.5% of all new cancer cases. Medicare
patients represented the largest portion of all patients (52.6%) and were most likely
to request follow up on Distress Assessment questionnaires, likely because
Medicare patients represent an older patient population or medically disabled
persons with complex needs and, therefore, requests for follow up on psychosocial
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questionnaires can be expected. Alternately, patients with commercial insurance
presumably represent younger or actively employed persons with greater access to
financial resources and support. Patients with commercial insurance were twice as
likely to participate in support groups, taking advantage of peer support
opportunities more so than other program resources suggesting a greater interest in
building a supportive, peer community.
•

Patients with advanced stage cancer were shown to use program services more
frequently and diversely. While patients with Stage IV cancer represented 19.7% of
all new cancer cases at PRCP, they represented 53% of multiuse participants.
Assuming patients with advanced stage cancer face greater emotional distress and
more complex psychosocial needs than patients with earlier stage cancer, advanced
cancer patients’ vast participation in program services affirms the mission of PSS to
meet the needs of patients in distress.

Patient perspective. Patient surveys sought to elicit areas of program strength based on
patients’ understanding of services or experience participating in services. Patient feedback
revealed many encouraging areas of program services and, in general, patients were likely to
express satisfaction and gratitude for the program. What follows is a summary of areas of patient
satisfaction based on 152 returned surveys.
•

Eighty-two percent of patients reported being informed of program services.

•

Emotional support was identified as the program’s greatest strength and most helpful
service provided by staff, with support groups being ranked second and resources and
financial support ranked third.
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•

The vast majority of patients reported high satisfaction with the quality (82.6%) and
variety (77.6%) of program services currently offered.

•

Eighty percent of patients reported satisfaction with staff access and responsiveness

•

Psychosocial services were perceived as a valuable part of cancer care treatment by
76.3% of patients.

•

Patients who had used program services were highly likely to continue using services
and to refer others to program services.

Staff perspective. Staff surveys aimed to understand how program services were used by
staff, what services were considered most valuable, and if the inclusion of psychosocial services
had an affect on staff as well as the larger cancer treatment program at PRCP. Forty-one staff
completed the survey identifying the strengths and value of program services from staff
perspective.
•

Sixty-eight percent of staff reported familiarity with program services.

•

The majority of staff regarded psychosocial services as being a valuable part of
cancer care treatment (92.7%) and having positive effects on patient outcomes
(85.4%).

•

Similar to patient feedback, staff also identified emotional support as the program’s
greatest strength.

•

All program services were recommended with high consistency among staff. Social
work was the most referred resource followed by counseling.

•

Staff reported being most likely to refer patients to program services under three
circumstances which support the goals and mission of PSS: When patient is upset,
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when family members have concerns or need support, and when a patient presents
with complex medical or psychosocial needs.
•

Staff were in high agreement of the perceived benefits of PSS. When psychosocial
services are offered in tandem with medical procedures to treat cancer, staff were
likely to endorse the beliefs that (a) patients are better able to cope with emotional
distress, (b) patients are less likely to develop severe emotional disorders, and (c)
patients are more likely to be satisfied with their cancer care. Additionally, staff
thought participation in program services was likely to increase compliance with
treatment recommendations and improve patients’ overall health and functioning.

Program Limitations and Recommendations
Program limitations were identified based on underutilized or underrepresented program
services as well as areas of dissatisfaction reported by patients and staff. Program
recommendations are offered with input from stakeholders to further benefit program services
based on identified areas of concern. In general, program recommendations may assist
stakeholders and staff delivering services in staying accountable to the program goals, mission,
and values, understanding program issues, examining areas of concern, refining program
planning, and making program decisions (Fitzpatrick et al., 2004).
In many instances, proposed recommendations affect more than one area of
improvement. For example, making improvements to staff and patient education, enhancing
outreach efforts, and modifying marketing materials may each have an aggregate affect on
program utilization and satisfaction of services. The proposed recommendations are offered as
considerations, not as prescriptive or required program changes.
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Utilization of services. While program strengths were identified based on areas well
utilized and well represented by patients, trends in program services that were underutilized or
underrepresented by patients were identified as areas in need of improvement. Feedback is
offered to diversify program services and reach patients who appear to be underserved by PSS
currently. Contextualized recommendations are proposed to improve services available as well as
program marketing and recruiting.
Diversity of services (gender). Although new cancer cases were represented by men and
women nearly equally at PRCP, PSS saw a significantly higher portion of women (68%) than
men (32%) participate in program services. Indeed, men represented less than a third of program
participants despite comprising 44% of all new cancer cases at PRCP. Of those men who
participated in program services, 15% represented group users and 36% represented multiuse
participants. In general, it appeared that men were much less likely than women to seek services
beyond an initial screening with PSS staff. It should be noted, however, that men diagnosed with
prostate cancer represent 5.5% of all new cancer cases at PRCP, but may never access PSS
because their treatment may be limited to surgical oncology or surveillance only, rather than
ongoing oncology care typical of other cancer diagnoses. Regardless, women demonstrated
much higher rates of utilization than expected compared to general demographics of PRCP
patients.
Proposed recommendations. Given the low frequency of men among program services
despite being near equally represented among new cancer cases, PSS is encouraged to modify
current marketing materials to recruit men with cancer more explicitly and encourage their
participation in program services. Further exploration is also recommended to better understand
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what program services men may be most interested in receiving as current program services may
not accurately reflect the needs of men with cancer.
Diversity of services (cancer). Breast cancer patients were superiorly represented among
all other program participants and, consequently, across all program services. While national
prevalence rates estimate that breast cancer comprises 14.6% of all new cancer cases (NCI,
2016), patients with breast cancer represented 19.4% of all new cases at PRCP and 34.8% of all
program participants in this evaluation. Breast cancer patients were represented at much higher
rates than expected, nearly one and half times the frequency of all other single and multiuse
participants and nearly ten times the frequency of all other group participants. Participation rates
of patients with other cancer diagnoses paled in comparison to the frequency of breast cancer
patients, despite similarly high national prevalence rates.
Proposed recommendations. The NCI (2016) projects breast, lung, prostate, colorectal,
bladder, melanoma, renal, leukemia and lymphoma, endometrial, and pancreatic cancers to be
the most common cancers among new cases diagnosed in 2016. PSS should make a concerted
effect to market program services to be inclusive and representative of the most commonly
occurring cancer diagnoses. Considerations should be made during program planning to recruit a
more diverse group of patients that parallels national prevalence rates and PRCP demographics.
A follow up analysis may evaluate why frequently observed cancer diagnoses are
underrepresented among PRCP cases and/or program participants. For example, male
reproductive cancers represent high national prevalence rates comparable to breast cancer
(11.2%), and yet represent only 6.5% of all new cases at PRCP and, as such, are significantly
underrepresented among program users as well.
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Support groups. Data from utilization of services indicated several considerations
regarding how support groups are currently structured and valued. Despite the ability of support
groups to capture a large and diverse audience, current support groups appear to be dominated by
a fairly homogeneous group, namely patients with early stage cancer and women with breast
cancer. In general, support groups were utilized less frequently than office visits and ranked
lower than emotional support and counseling services by patients and staff alike. Indeed,
evidence of the underutilization of support has been present as far back as 2005, when
psychosocial services were offered as ambulatory services prior to PRCP being built (PRCP,
2005b). Anecdotally, past and present PSS staff reported low weekly attendance among support
groups with few new patients returning beyond an initial support group meeting. Although
support groups have received mixed feedback from patients and staff, they have the potential to
provide substantial support to a large audience and deserve more attention to ensure their
usefulness.
Proposed recommendations. Given the mixed feedback support groups received from
patients and staff alike, it is worth evaluating how support groups are currently utilized,
including the diversity of attendees and the ratio between new and returning attendees.
Utilization data indicated that support groups are currently dominated by a fairly homogenous
patient population; because of the advantages support groups have in reaching a broad
community, attention should be paid to how support groups can recruit a more diverse audience
that encompasses commonly occurring cancers at PRCP.
PSS is encouraged to consider how support groups are currently structured to evaluate
how many support groups may be necessary to meet the emotional needs of patients, caregivers,
and family members. Future program planning may investigate whether current support groups
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should be consolidated to reach a higher volume of patients rather than a specialized population,
for example support groups for all men or all women with cancer rather than focusing on prostate
or breast cancers. Additionally, the structure of support groups should be evaluated to consider
the benefit of offering open verses closed groups requiring preregistration or groups held for a
specified length of time rather than ongoing. An appraisal of support groups may also consider
what areas of interest tend to attract a higher volume of attendees to improve support group
content and recruiting efforts. For example, in the past, guest speakers have attracted a high
volume of attendees and it may be worth allocating funds toward speakers to increase the overall
value of support groups.
Satisfaction of services. Using surveys, patients and PRCP staff were invited to submit
feedback and ideas to improve PSS services. In total, 48 responses were received, 16 from
patients and 32 from staff members. Responses were organized based on shared themes and
categorized into three identified areas for improvement: (a) education and outreach, (b) services
and access, and (c) PSS staffing.
Education and outreach. Results from patient and staff surveys indicated education and
outreach as an area in need of improvement. Patients requested staff members place greater
emphasis on utilizing “integrative services,” or services available beyond standard medical
treatments. PRCP offers several ancillary support services under the umbrella of integrative
health, including acupuncture provided by practitioners of Bastyr University, naturopathic
medicine, nutrition classes with a registered dietician, and behavioral health and counseling
services provided by PSS. In addition, the Cancer Resource Center, staffed by the knowledgeable
Patient Navigator and volunteers from the American Cancer Society, offers a plethora of
literature on cancer and treatments as well as resources such as hats, wigs, port pillows, and
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camisoles to support breast prostheses. Palliative Care clinicians help manage treatment-related
symptoms and pain control, focusing on preserving patients’ quality of living and chaplains
employed through Providence Medical Center are available for spiritual care and emotional
support. For the purpose of this evaluation, data was collected primarily on behavioral health and
departments that worked most closely with PSS including nutrition and the Cancer Resource
Center; acupuncture, naturopathic medicine, Palliative Care, and Spiritual Care were not
explicitly evaluated.
Staff education. According to staff surveys, only 37% of PRCP staff made referrals to
PSS “often” and 39% of staff referred “sometimes.” While the vast majority of staff (92.7%)
agreed that psychosocial services are a valuable part of cancer care treatment, 32% of staff
reported being unfamiliar with PSS. Furthermore, patients felt their treatment providers did not
actively encourage PSS services as part of their treatment. Better staff education is necessary to
help PSS to retain its importance and value within the cancer treatment center. After all, a robust
integrative health department is only as valuable as the use it receives from patients. Staff
education and encouragement to use supportive services can breathe new life into ancillary
services and provide the recognition integrative health deserves.
PSS staff is encouraged to create a quarterly newsletter to advertise program services and
introduce PSS staff members and areas of specialty or interest. Because a majority of PSS is
comprised of psychology interns, the department sees a fair deal of staff turnover annually; in
essence, the department changes with each new cohort of interns and PRCP at large needs a
better way to acclimate to program and staffing changes. Newsletters are a great way to
familiarize PRCP with the most accurate department information, including program services,
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referral information, and current staff members. It would follow that greater familiarity with PSS
staff and program services would generate more frequent referrals from treatment providers.
The more visible PSS staff are throughout the cancer program, the more familiar PRCP
staff will be with staff members, program services, and procedural policies. As such, PSS is
encouraged to have a department representative attend quarterly all staff service meetings and
daily cancer specialty conferences. Greater involvement from PSS staff within the Cancer
Partnership reinforces the mission of PRCP to provide comprehensive cancer care. To that effect,
PSS should be represented among the other disciplines as often as possible. Similarly, PRCP
staff should also be more involved in understanding PSS services to help bridge the gap between
disciplines and departments. During new employee orientation, new staff hires should meet with
PSS staff and shadow their position to learn about the department first hand, as they do with
providers in other departments.
Patient education and outreach. While staff education can help increase referrals to PSS
and strengthen multidisciplinary, integrative cancer care, patient education and outreach is
needed to ensure program services are reaching their intended audience. Although all patients to
receive a paper-and-pencil screening for psychosocial distress meant to identify patients in need
of outreach and support services, not all patients meet PSS staff or understand the full breadth of
services available to them and their family members.
Patients expressed the need for more information on available program resources, both in
print and in person. Similarly, PRCP staff requested program services be explained to patients
more thoroughly or explicitly at the beginning of treatment. Because patients are initially focused
on understanding their diagnosis and treatment options, information they receive upfront is
heavily focused on treatment education and less on ancillary services. The general census of PSS
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staff is to provide PSS outreach shortly after patients have had a chance to acclimate to their
treatment schedule, presumably when they are better able to absorb additional information and
consider adjacent services to support their cancer care. PSS is encouraged to consider delivering
patient education in-person on a regular basis. A monthly “meet and greet” table can be set up in
high traffic areas such as infusion or waiting rooms to increase PSS visibility and provide inperson education. Printed program materials can be easily advertised and distributed, and
patients and staff alike can also become more familiar with PSS staff in a personable, informal
manner. A meet and greet table also brings awareness and education directly to patients, quite
literally meeting patients where they are rather than relying on them to seek out program services
on their own.
Because patients receive oncology services on the second and third floor of the Cancer
Partnership, services located on the first floor do not regularly receive foot traffic from patients.
Additionally, many services aren’t easily noticeable as they occur behind locked doors, a part of
the building not accessible to patients unless accompanied by staff. A team of receptionists and
schedulers were previously staffed on the first floor, which drew greater attention to first floor
services in general and also helped direct patients to services as needed. Reinstating staffing on
the first floor of the building where ancillary services are housed may also increase visibility and
awareness of program services and create a more engaging atmosphere on the first floor.
Marketing and advertising. The more marketing materials are made easily and readily
accessible, the more patients and staff can be accurately informed of program services, eligibility
(when appropriate), and how to reach PSS. In general, better marketing and up-to-date
advertising may reduce confusion and inaccuracies in program services that have potentially led
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to areas of dissatisfaction in the first place. Clearer and more accessible program information
may improve patient education and help patients better utilize program services.
Marketing materials should be frequently monitored to ensure the most accurate
information is being advertised. In addition to marketing materials being placed in highly visible
locations throughout the Cancer Partnership, fact sheets answering frequently asked questions
can be created and stored at nursing stations in infusion. Oncology nurses spend a great deal of
time interacting with patients as they deliver chemotherapy and other treatments and, as such,
nurses often screen patients for distress and serve as a primary point of contact for patients to
learn about ancillary services. Nurses could easily distribute fact sheets with up-to-date
information on frequently requested resources such as transportation services, Washington
Medicaid Programs such as Community Options Program Entry System (COPES), and Social
Security Disability Insurance Program (SSDI). Fact sheets would also serve to educate PRCP
staff on resources that receive a great deal of attention within the Cancer Partnership and
improve the working relationship between PSS and other departments creating a more cohesive
experience for patients.
In addition to traditional marketing materials (i.e., business cards, flyers, printed
brochures), PRCP should consider investing in television monitors that digitally display
information about PRCP at large. Television monitors have the advantage of displaying a variety
of information to a large audience rather than printed brochures that patients have to seek out on
their own. Additionally, digital information can be easily updated or edited without having to
reprint materials. Television monitors can be positioned in waiting areas or infusion where
patients are gathered for long periods of time. Advertised information could include PRCP staff
biographies and specialties, clinical research trials, upcoming events, and program services.
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Program services can also be advertised while callers are placed on hold during telephone calls
to PRCP.
Services and access. In general, patients expressed high satisfaction regarding the
quality and variety of program services. However, transportation, hospice care, and family
services were identified as areas in need of improvement.
Transportation. Satisfaction surveys demonstrated transportation services were a highly
valued service and appeared to be well utilized by patients. In many instances, transportation
services were rated as a program strength. Additionally, 63% of staff reported making referrals to
PSS for patient transportation needs, indicating a highly visible service within the department.
PSS is advised to create handouts advertising available transportation services to clarify
rider eligibility requirements and inform staff and patients how services can be utilized and
arranged. Brief, fact-based handouts should be placed in high traffic areas such as infusion,
waiting areas, and nursing stations for easy access and reference to available services. Because
available transportation services are limited based on rider eligibility requirements, PSS is urged
to consider allocating funds toward alternate transportation options to assist patients with
transportation hardships. Funds could be put towards purchasing ferry tickets, bus fare, taxicab
vouchers, or additional gas gift cards.
Concerns regarding transportation services may have more to do with available
transportation services and rider eligibility requirements than deficits in how PSS utilize
services. Further evaluation is recommended to determine specific areas of dissatisfaction within
transportation services.
Hospice care. Patients receiving hospice care were marginally represented throughout
this evaluation, despite Palliative Care having a strong presence at PRCP. Indeed, of the 152
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patient surveys, only one respondent indicated receiving hospice care and two respondents
reported involvement with Palliative Care. Nevertheless, providing compassionate end-of-life
care is an essential component treating progressive illness and requires more attention than this
evaluation could provide.
While advanced stage cancer represents a high percentage of all cancer cases at PRCP
(19.7%) and, therefore, many patients who eventually face the final stages of their illness, it is
unclear how well hospice care is utilized within the Cancer Partnership and what role PSS could
provide in helping patients transition onto hospice. Further evaluation is recommended to better
understand how and when referrals to hospice are made and how PSS might provide assistance.
Family services. Both patients and staff surveyed requested more support opportunities
for family members and caregivers. Interestingly, the inclusion of family members in program
services occurred quite frequently and organically. Indeed, 17% of single-use participants, 42%
of multiuse participants, and 37% of group users involved family members in their care and PSS.
However, data from the current evaluation did not distinguish family members who participated
in program services for their own needs from those who participated in program services for the
primary purpose of supporting the person affected by cancer. Effects of cancer on caregivers and
family members are well documented (see IOM, 2008 for a review of relevant research), and as
such, a strong argument can be made to ensure program services are offered explicitly for
caregiver support.
Currently, PSS does not offer any resources explicitly for caregivers, though family
members are welcome to participate in most program services including counseling and the
majority of PSS support groups. A Caregiver Support Group previously existed, but has since
been consolidated into a general support group due to low attendance numbers. Family members
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do appear to be present among a variety of program services as indicated by utilization of
services results, however, how family members utilize services and for what purpose remains
unknown. PSS is encouraged to consider how family members and caregivers can be better
supported through program services, both for their own benefit and to support loved ones going
though cancer. Marketing materials should be modified to inform and encourage caregivers of
support opportunities geared specifically towards them.
PSS staffing. Staffing concerns were the most frequently critiqued area within the
department. Patients and staff identified PSS staffing concerns including staff training and
consistency in care provided, staff access, and staff response time on urgent needs. Proposed
recommendations focus on understanding staffing concerns based on the current model of care.
Staff training and consistency. Patients reported dissatisfaction with PSS staff training
and education as well as inconsistencies receiving care from PSS staff. Training and consistency
concerns may be related to the annual turnover rate of PSS staff given the department’s reliance
on psychology and social work interns to supplement PSS staffing. Current PSS staffing consists
of a half-time psychologist who also serves as the medical director of program services and a
social worker who is employed 32 hours per week. On average, one or two psychology interns
join the department for a twelve-month contractual learning agreement to complete clinical
training requirements. Modifications to PSS’s internship training curriculum may address
concerns regarding staff education and inconsistencies and in care provided.
The Medical Director of Psychosocial Services is encouraged to create a standard training
program with specific learning modules based on department needs to improve consistency and
education among staff and interns. Procedural flow charts should be created to help staff identify
available resources and program services based on the level of patient care needed. Examples
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could include procedural diagrams on when and how to complete applications for Washington
Medicaid Programs (i.e., Community Options Program Entry System, COPES), Social Security
Disability Insurance Program (SSDI), and PRCP’s Patient Assistance Fund for patients
experiencing financial hardship.
Staff access. PRCP staff expressed critical feedback regarding PSS staffing access
including staff availability, visibility throughout the Cancer Partnership, and lack of full-time
staffing. Recommendations are proposed to improve accessibility and consider overall staffing
conditions. Visibility concerns may be improved secondarily by addressing staff access as well
as proposed recommendations to improve PRCP staff education, patient outreach, and program
marketing, as previously discussed (see education and outreach section above).
PRCP staff indicated difficulty reaching PSS by phone during regular business hours and
a request was made for PSS staff to be more available for referrals and immediate concerns. A
centralized phone number is recommended to reach all PSS staff and, thereby, improve staff
accessibility. Currently, two phone numbers exist for the department based on office staffing—
one number reaches the designated social worker, while another number reaches interns and the
Director of program services. A separate number is also utilized to reach staff by pager, for
example when staff are outside the office visiting patients in infusion or patients hospitalized in
an adjacent building. All PSS staff generally provide the same services and work in close
proximity to one another, eliminating the need for two distinct phone numbers; a centralized
phone number would likely improve accessibility and reduce confusion among staff trying to
promptly reach PSS.
Again, it is worth noting that a good portion of PSS staffing is comprised of psychology
interns, generally constituting at least half the department’s staff. Specific requests were made by
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PRCP staff to expand current PSS staffing conditions including first floor reception staff, a fulltime social worker, and a full-time nutritionist or dietician. Because current staffing conditions
affect available program services, satisfaction of services, consistency and quality of services
provided, and department accessibility or visibility, the current staffing model should be further
evaluated. More specifically, the long-term sustainability of PSS should be evaluated based on
PSS’s current staffing conditions and reliance on qualified psychology interns. Furthermore, the
ratio of full-time PSS staff to all PRCP patients should be evaluated and compared to other
cancer treatment programs to determine if PSS’s current staffing model is similar and/or
sufficient. It should be noted that since 2010, the Medical Director of Psychosocial Services has
sought to identify ways to rely less heavily on students/interns and increase hiring practices for
permanent staffing (K. Johnson, personal communication, 2013; PSS, 2010), recognizing the
sustainability of quality, consistent staffing as an area of concern the past several years.
Response time. In addition to difficulty reaching PSS staff, PRCP staff indicated
dissatisfaction with PSS response time on urgent matters such as calls, pages, and Distress
Assessment questionnaires with marked levels of high distress. Additionally, results from the
staff survey rated PSS staff’s ability to triage patients with high acuity as a relatively low
department strength, indicating a consistent concern from staff about how PSS attends to patients
in high or immediate need. Interestingly, patient surveys indicated high satisfaction concerning
both PSS staff access and responsiveness, reflecting differences among patient and staff
perceptions.
Concerns regarding the immediacy of PSS staff responding to perceived urgent needs is
an area that requires further evaluation. Poor response time on urgent matters may reflect a
variety of concerns, for example understaffing, poor staff accessibility, or insufficient education
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about how PRCP staff can use and access PSS resources. The fact that staff reported low
satisfaction with PSS response time but patients did not indicate an interesting discrepancy
between staff and patient perceptions, which is worth investigating. To better understand
concerns, PRCP staff should be interviewed to identify specific areas of concern and how
concerns may be addressed. Additionally, quality assurance measures should be reviewed to
monitor response time on urgent referrals made by staff and Distress Assessment questionnaires
to corroborate concerns. It is possible that recommended improvements regarding PSS staff
accessibility and PRCP staff education may secondarily address response time concerns.
Stakeholder Feedback Sessions
Three feedback sessions were held to present evaluation findings and invite stakeholders
to participate in how findings can be used to improve and advance program services. The
intended audience of this evaluation was PSS staff who deliver program services as well as
program administrators who have input in making overall program changes. Feedback sessions
were tailored to the audience of each meeting and delivered in multiple formats to make
information easily accessible and engaging (Fitzpatrick et al., 2004). In alignment with the
collaborative methodology of program evaluations, stakeholders were intentionally and
continuously involved in the entirety of this evaluation (Preskill & Jones, 2009) which
undoubtedly shaped the usefulness and credibility of program findings and recommendations.
The first stakeholder feedback session was held during the quarterly Psychosocial
Steering Committee, the same meeting where areas of evaluation interest were first generated the
prior year. Nine staff members were present during the feedback session, including members of
the management team (Executive Director of PRCP and administrative executive) as well as
supporting specialists (Medical Director of Psychosocial Services, American Cancer Society
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representative, and Patient Support Services clinical staff). A PowerPoint presentation outlined
evaluation findings and identified areas for improvement. An informal follow up meeting was
held during the weekly PSS meeting to further discuss areas of feedback and generate program
recommendations. Six staff attended the follow up meeting representing the current PSS team
entirely and a representative from ACS.
A final feedback session was held during the quarterly Cancer Executive Committee
meeting, the forum for discussing organizational recommendations for strategic and business
development. Program findings and proposed recommendations based on stakeholder input were
presented to leadership as part of the dialogue on the growth and development of PRCP at large.
Fourteen members were present including the Vice President and Chief Medical Officer of
PRCP among physicians and administration representative of medical oncology, radiation
oncology, diagnostic radiology, and surgery.
Evaluation Limitations
Several limitations of this evaluation and its methodology are noted. First, utilization of
services data did not represent an exhaustive review of all patients who participated in program
services nor all staff members who provided services. Patient names were selected for auditing
based on staff charting records, July 2014–June 2015 for group participation and January–June
2015 for individual or family interaction. Four hundred chart audits were decidedly selected to
allow for comparisons between groups—single-use participants, multiuse, and group users—
though more chart audits could have easily occurred. Selecting electronic health records for
review in this manner was somewhat arbitrary and neglected many people may have participated
in program services. For example, data did not include men who attended the prostate cancer
support group since it was not facilitated by PSS staff. Data also did not accurately capture
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family members who received support services since there was no way to verify information or
collect data using electronic health records unless family members were also oncology patients.
In other instances, PSS may have provided services to persons with cancer who were treated
outside PRCP; for example, support groups were open to all persons with cancer and attracted
people who have/had received treatment elsewhere, but live near PRCP and chose to participate
in program services. Again, unless an electronic health record was available for review, these
persons were not included in the analysis. Data was also not available for patients who received
services from the Medical Director of Psychosocial Services or the social work intern who began
working with the department midway through this evaluation. It would seem there were many
exceptions to how data was collected for chart review and, thus, results did not wholly
encompass program participants. Had utilization of services represented all patients who used
program services during a one-year span, more inferences could have been made generalizing
how services were utilized and by whom. For example, it may have been useful to know how
many patients were served by PSS compared to all new cancer cases at PRCP. Instead of a
comprehensive and exhaustive analysis of program utilization, observed trends were noted and
recommendations made for further evaluation as indicated.
The methodology used to collect survey data also contained shortcomings. For the most
part, patient and staff surveys consisted of forced choice, Likert scales to easily capture
respondents’ attitudes and opinions and to identify trends based on positive or negative feedback.
A substantial limitation to forced choice responses on surveys was the dearth of specificity
captured in responses. While forced choice surveys may have encouraged a high response rate
given the relative ease of completing surveys, they lacked specificity and detail in their
responses. In this evaluation, it would have been helpful to have more information when patients
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or staff indicated areas of concern. Specific examples or scenarios illustrating areas of concern or
criticism may have helped better inform treatment recommendation and ensure future changes
address areas of concern based on feedback. Interviews were not conducted to limit the scope of
this evaluation, though future interviews could explore areas of feedback more thoroughly to
provide a more in-depth analysis of perceived areas of strength and weakness.
While this evaluation focused specifically on services provided by Patient Support
Services, other departments within integrative services were included in the data as well.
Information about nutrition services, the Cancer Resource Center, and financial assistance were
included given the proximity of those departments working with PSS. However, combining
integrative services with PSS made it difficult to delineate which services were utilized and
criticized at times. For example, some survey respondents indicated attending a support group,
but listed the Look Good Feel Better class offered through the Cancer Resource Center, which is
not facilitated by PSS staff. Additionally, financial assistance could refer to PSS staff helping
patients apply for SSDI, completing an application for the Susan G. Komen breast cancer fund,
or PRCP’s financial assistance fund, or, alternately, could refer to assistance provided by PRCP’s
financial advisors who oversee insurance coverage and billing questions. Small distinctions in
language may have also produced skewed results on survey questions. For example, the phrase
“social work” was used to imply working with a PSS staff member to gather resources or help
with financial assistance; however, respondents may have assumed that meeting with a social
worker (verses psychologist or intern) for any reason (i.e., emotional support, family counseling)
was “social work,” thus misrepresenting the services actually used. Respondents may have also
struggled to differentiate between “emotional support during treatment” (meant to convey
services received during infusion, radiation, or hospitalization) from “counseling” (meant to
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convey individual or family psychotherapy or counseling generally received in the office).
Again, a clear limitation of using surveys to collect data was that respondents were unable to ask
for clarification and the evaluator was unable to ask respondents any follow up questions.
A final limitation of this evaluation was its intended scope. From the beginning, this
formative evaluation sought to evaluate a part of PSS, not the summation of program services.
Therefore, limitations of this evaluation were inherent given the finite scope of services reviewed
for feedback. In the future, a summative evaluation may be conducted to further assess PSS’s
value and to help program personnel make decisions concerning the program’s continuation or
expansion (Fitzpatrick et al., 2004). Lastly, while this evaluation identified program strengths
and recommendations to address areas of improvement, the organization is responsible for
deciding whether to implement recommendations and to use evaluation findings as one tool in
understanding and enhancing program services.
Conclusion
This program evaluation provided an overview of psychosocial services as they are
utilized and valued by patients and staff. Nine years since the inception of Providence Regional
Cancer Partnership, this evaluation took a first look at how Patient Support program services
were utilized and by whom. Results identified program strengths indicated by areas well
represented by patients. Patients with advanced stage cancer were highly represented among
program participants as well as patients with presumed financial distress. Program
recommendations were provided to improve areas underutilized and underrepresented by
patients, in particular identifying the need to diversify program services to more closely reflect
expected gender and cancer demographics compared to national prevalence rates (NCI, 2016)

128
and PRCP population statistics. Additionally, a proposal was made to further evaluate support
groups based on utilization trends and mixed feedback.
In addition to program utilization data, satisfaction surveys were distributed for the first
time since 2009 providing feedback concerning areas of satisfaction and dissatisfaction. Survey
data revealed many program areas of strength and satisfaction including the department’s ability
to provide emotional support, high quality and variety of program services, and the program’s
overall value as part of a larger cancer treatment center. Areas for improvement were categorized
into three themes reflecting shared concerns: patient education and outreach, program services
and access, and PSS staffing. Thoughtful and informed recommendations were presented with
collaboration from stakeholders to improve program services and further benefit PRCP’s patient
population. Upon implementing recommendations, PSS may see remarkable differences in more
than one area identified as a concern. For example, concerns regarding staff access and visibility
may be resolved secondarily by improvements made to PRCP staff education, patient outreach,
and program marketing.
In general, this evaluation clarified areas of strength and areas recommended for
improvement. During multiple stakeholder meetings, feedback was provided about the general
efficacy of program services and the merit of Patient Support Services within the larger Cancer
Partnership. Subsequently, results of this evaluation validated staff efforts to enact the mission of
PSS: To provide psychosocial services to some of PRCP’s patients in greatest need. Results from
this evaluation can be referred to throughout the program’s existence to monitor PSS’s adherence
to the program’s goals and mission and to continue assessing its efficacy in providing program
services that are well utilized and valued.
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•
•
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•
•
•

•
•
•
•

•

Distress should be recognized, monitored, documented, and treated promptly at all stages
of disease and in all settings.
Screening should identify the level and nature of the distress.
Ideally, patients should be screened for distress at every medical visit as a hallmark of
patient-centered care. At a minimum, patients should be screened for distress at their
initial visit, at appropriate intervals, and as clinically indicated, especially with changes in
disease status (i.e., remission, recurrence, progression, treatment-related complications).
Distress should be assessed and managed according to clinical practice guidelines.
Interdisciplinary institutional committees should be formed to implement standards for
distress management.
Educational and training programs should be developed to ensure that health care
professionals and certified chaplains have knowledge and skills in the assessment and
management of distress.
Licensed mental health professionals and certified chaplains experienced in psychosocial
aspects of cancer should be readily available as staff members or by referral.
Medical care contracts should include reimbursement for services provided by mental
health professionals.
Clinical health outcomes should include assessment of the psychosocial domain (e.g.,
quality of life and patient and family satisfaction).
Patients, families, and treatment teams should be informed that distress management is an
integral part of total medical care and provided with appropriate information about
psychosocial services in the treatment center and the community.
Quality of distress management programs/services should be included in institutional
continuous quality improvement (CQI) projects.
(NCCN, 2016b, p. DIS-3)
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Diagnostic Imaging
Angiography
Bronchoscopy
Computerized Axial Tomography Scan
Digital Radiography for Mammography
Echocardiography
Electromagnetic Navigational Bronchoscopy
Low-dose CT Screening
Magnetic Resonance Imaging
Magnetic Resonance Mammography
Mammography
Mediastinoscopy
Nuclear Medicine
Positron Emission Tomography Scan
Stereotactic Guided Biopsy
Ultrasound
Clinical Research
Prevention
Quality of Life
Screening
Treatment
Medical Oncology
Biotherapy
Chemoembolization
Hormone Therapy
Immunotherapy
Infusion Center with Chemotherapy
Plasmapheresis
Surgery
Cryosurgery
da Vinci Robotic Assisted Procedures
DIEP Flap Breast Reconstruction
Laparoscopic Surgery
Limb Infusion
Mammosite
Microwave Ablation
Sentinel Lymph Node Biopsy
Ultrasonic Surgical Aspiration
Video Assisted Thoracic Surgery
Radiation Oncology
3D Conformal Radiation Therapy
Brachytherapy (High Dose Rate)

Brachytherapy (Low Dose Rate)
Computerized Treatment Planning
Electron Beam
External Beam Radiation Therapy
Extracranial Radiosurgery
MammoSite Radiation Therapy
Image-Guided Radiation Therapy
Intensity Modulated Radiation Therapy
Linear Accelerator
Prostate Seed Implant
Respiratory Gating
Stereotactic Radiosurgery
Systemic Radioisotopes
Support Services
Acupuncture
Advanced Care Planning
Art Therapy
Breast Pain Clinic
Cancer Resource Center
Caregiver and Family Counseling
Classes and Support Groups
Distress Assessment
Integrative Medicine Services
Fertility Counseling
Financial Counseling
Genetic Counseling and Testing
Healing Spirit Boutique
Home Care Program
Hospice
Lodging Assistance
Mastectomy Education
Mind-Body Medicine
Naturopathic Medicine
Nutrition Counseling
Pain and Symptom Management
Palliative Care Services
Pastoral Care
Patient Navigator Program
Prosthetic Services
Rehabilitation Therapy
Smoking Cessation Program
Survivorship Program
Transportation Assistance
Wellness Program
Wound Care Clinic

(PRCP, 2014)
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Primary Site
Brain
Cranial nerves & nervous system
Oral cavity & pharynx
Esophagus
Larynx
Thyroid
Other endocrine
Lung
Mesothelioma
Breast
Liver & intrahaptic bile duct
Stomach
Pancreas
Kidney & renal pelvis
Small intestine
Colon
Bladder
Rectum & rectosigmoid
Anus, anal canal, anorectum
Cervix uteri
Corpus uteri
Ovary
Vulva
Prostate
Testis
Leukemias
Lymphomas
Multiple myeloma
Melanoma
Soft tissue
Other
TOTAL

# of Cases
33
47
40
26
9
44
20
275
4
370
25
20
36
56
4
89
92
58
9
21
94
35
13
105
17
47
82
24
64
6
139
1,904

Male
21
16
35
20
7
19
9
142
4
2
16
13
15
39
4
47
71
36
1
----105
17
15
50
17
28
4
84
837

Female
12
31
5
6
2
25
11
133
0
368
9
7
21
17
0
42
21
22
8
21
94
35
13
--7
42
7
36
2
70
1,067
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Primary Site
Oral cavity & pharynx
Esophagus
Larynx
Thyroid
Lung
Mesothelioma
Breast
Liver & intrahaptic bile duct
Stomach
Pancreas
Kidney & renal pelvis
Small intestine
Colon
Bladder
Rectum & rectosigmoid
Anus, anal canal, anorectum
Cervix uteri
Corpus uteri
Ovary
Vulva
Prostate
Testis
Lymphomas
Melanoma
Soft tissue
Other
TOTAL

Stage I
2
9
3
24
71
1
160
6
5
3
30
0
20
19
12
5
10
74
5
7
16
17
23
32
3
4
561

Stage II
1
2
2
3
29
1
112
4
3
7
6
0
24
10
17
2
3
3
7
0
53
0
19
12
1
5
326

Stage III
4
6
1
9
40
0
31
4
4
2
8
2
20
4
13
1
4
9
16
0
20
0
16
7
1
12
234

Stage IV
32
9
3
7
134
1
12
10
8
23
9
2
22
9
13
0
3
7
6
2
16
0
34
3
1
9
375
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Primary Site
Brain
Cranial nerves & nervous system
Oral cavity & pharynx
Esophagus
Larynx
Thyroid
Other endocrine
Lung
Mesothelioma
Breast
Liver & intrahaptic bile duct
Stomach
Pancreas
Kidney & renal pelvis
Small intestine
Colon
Bladder
Rectum & rectosigmoid
Anus, anal canal, anorectum
Cervix uteri
Corpus uteri
Ovary
Vulva
Prostate
Testis
Leukemias
Lymphomas
Multiple myeloma
Melanoma
Soft tissue
Other
TOTAL

Private
19
18
24
11
4
31
9
68
1
189
4
11
10
17
1
37
26
27
2
13
29
13
0
37
11
16
30
4
28
4
31
725

Medicaid
3
3
1
0
2
2
3
19
0
34
3
0
3
3
1
5
5
2
1
3
10
3
1
8
2
3
9
2
4
0
7
142

Medicare
11
23
12
15
3
11
7
185
3
147
18
9
23
35
2
47
60
27
6
5
52
18
12
57
0
27
52
18
31
2
84
1,002
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Psychosocial Services Policy and Procedures: Access to Psychosocial Services
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PURPOSE
The purpose is to ensure that all patients, family members, and caregivers have access to
psychosocial services. Psychosocial services are essential components of comprehensive cancer
care and are provided to patients with cancer and their caregivers throughout the continuum of
care. These services address physical, psychological, social, spiritual, and financial support needs
that result from a cancer diagnosis and help ensure the best possible outcome.
PSYCHOSOCIAL SERVICE PROVIDERS
A variety of psychosocial services are available on-site, most at no cost, to all patients and their
caregivers. These services are provided by the following disciplines:
• Chaplain
• Psychologist
• Clinical social worker
• Registered dietician
• Interns in the fields of clinical psychology and social work
• Financial counselors
• Clinical nurse specialist
• American Cancer Society volunteers
POLICY
• All patients, family members, and caregivers have access to the full range of
psychosocial services
• Individuals who are not receiving treatment at PRCP are also welcome to attend the
support groups and classes at PRCP
• Patients may be referred for services by their physician, nurse, or any staff member
• Patients and caregivers may self-refer for all groups, classes, and individual services
• If the needed service is not available on-site, Patient Support staff will provide
appropriate community referrals
• Both on-site and community resources are available on the PRCP website. Brochures and
flyers outlining the available services are available and displayed on each floor of the
Cancer Partnership, as well as in the Cancer Resource Center
• Each patient’s needs for services are routinely monitored through the use of the distress
assessment tool
• Once a need is identified, the patient will be informed of available services either by
phone, in person, or by mail
DOCUMENTATION
• Support group attendance is reported monthly to the Cancer Partnership administration
• Individual services are documented as notes in the patient’s electronic health record
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AVAILABLE GROUPS AND RESOURCES
The following is a list of services typically available on-site. Specific groups are subject to
change based on the current needs and requests of patients at any given time.
• Supportive counseling
• Support groups
• Assistance with resources
• Spiritual support
• Assistance with Advanced Directive, Living Will, and Durable Power of Attorney for
Health Care
• Nutritional counseling
• Financial counseling and assistance for uninsured and underinsured patients
(PRCP, 2012c)
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Providence Regional Cancer Partnership Support Resources

149
Support resources add an extra dimension of care to fight your cancer and promote your health
on every level—body, mind and spirit. You can count on the attention and knowledge of leading
practitioners in their fields who are devoted to helping you feel better and get better.
Cancer Resource Center
The Cancer Resource Center is a quiet, comfortable place for patients, families and caregivers to
find information on cancer, log on to the internet, or talk with a Patient Navigator or volunteer.
It’s also a convenient source for the latest information on cancer tests, treatments, clinical trials,
and local resources for support groups and transportation services. A wide variety of literature on
cancer and treatment is here for you, free of charge.
Patient Navigator
At the Cancer Partnership, you’ll have a Patient Navigator who is dedicated to answering
questions, providing resources and suggesting support services throughout your treatment
and beyond. This highly-trained cancer expert is part of the American Cancer Society
Patient Navigator Program, a respected network that follows national standards, offers
extensive training, and serves patients at more than 60 sites around the country.
The Patient Navigator is here to listen, care and help, so you never have to wonder where
to turn. You can count on your Patient Navigator to:
• Provide information on what to expect during chemotherapy and radiation, and on
dealing with any side effects of treatment.
• Share resources with you for financial assistance, medication needs, home health
care, insurance, transportation and other concerns.
• Refer you to groups, classes and support programs.
• Connect you with helpful resources in your community.
• Suggest activities that can help ensure a better quality of life both during and after
treatment.
Healing Spirit Boutique
The Healing Spirit Boutique is a special place in the hearts of many cancer patients. It is
here to provide free hats, wigs and understanding to patients experiencing appearancerelated changes during cancer treatment. The boutique is staffed by volunteers who are
experienced in finding and fitting the right style and hair color of wig, along with
complementary cosmetics.
Classes
Classes at the Cancer Partnership are open to all patients, family members, friends and
caregivers. They’re a great way to build your support network and engage in the healing process
with others who understand. Classes are also open to the general public and to cancer patients
who are not patients of the Cancer Partnership.
Art therapy
Art therapy increases your awareness of yourself and others and is a great therapeutic tool
for cancer patients. It is fun and life-affirming, and enhances cognitive abilities. This
class offers a supportive, non-judgmental environment, and no artistic ability is
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required. Our art therapists, trained in both art and therapy, offer guidance and support,
as well the opportunity to explore a variety of art materials.
Gentle yoga
Reconnect with your body and learn how to be gentle with yourself in a fun,
noncompetitive environment. Wear comfortable clothes, and bring a mat and water
bottle. This non-aerobic form of exercise concentrates on movements and deep breathing.
It can help reduce stress and fatigue, as well as improve sleep. Exercise promotes healing
and well-being during cancer treatment and can help accelerate your long-term recovery
process.
Look good. Feel better.
The name of this unique program says it all. Sponsored by American Cancer Society, it’s
designed for women going through the effects of cancer treatment. Classes focus on skin
and hair care, cosmetics, wigs and head wraps, dealing with hair loss, and getting healthy
nutrition. Cosmetic samples and makeovers are available. All cosmetic products for your
makeover are complimentary and provided for you to enjoy and take home with you.
Nutrition
Learn about the foods that can strengthen your immune system, improve your energy,
and maintain a healthy weight. Our free monthly nutrition class is dedicated to helping
patients, survivors, family members and other caregivers improve their health through
better eating.
Counseling Services
When you receive a cancer diagnosis, it’s natural to have questions and concerns. You may also
need some extra support for yourself and your loved ones. After all, a cancer diagnosis affects
everyone in the family in many ways.
Our Patient Support Services Team is available by appointment to provide one-to-one counseling
and help you address any of the following concerns:
• Coping with a new diagnosis, treatment or recurrence
• Creating a care team at home
• Family communication
• Support in making difficult treatment decisions
• Self-care for patients and caregivers
• Stress management
• Identifying resources
• Anxiety and depression
• Grief and loss
• Survivorship concerns
• End of life concerns
Individual, group, and family counseling services are also available at no cost to Cancer
Partnership patients and family members. Counseling services are provided by Masters-level
trained clinicians working closely with cancer patients and their families. They’re good listeners
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and problem-solvers who are here to address the psychological, social, cultural, financial and
continuing care needs of you and your family.
Financial Counseling
We believe everyone should have access to quality healthcare. If the financial side of cancer
treatment is a worry for you, we encourage you to talk with our financial counselors. Financial
counselors verify benefits, help develop a payment plan for treatment, and obtain outside
assistance if necessary.
Patient Assistance Fund
The Linda Baltzell Patient Assistance Fund (PAF) was established in 1978 for patients
who needed financial support, particularly paying their medical bills while they were
receiving radiation treatments. The PAF today supports Cancer Partnership patients who
are receiving chemotherapy and/or radiation and need financial assistance with rent, gas,
groceries, medication, clothing, etc. (PRCP, 2015a).
Integrative Medicine
Integrative medicine offers a unique approach to healing. Services include a variety of
complementary treatment options so patients are able to achieve maximum benefit and symptom
relief. Care is coordinated with patient’s chemotherapy and radiation treatment (PRCP, 2014).
Naturopathic Medicine
Naturopathic medicine is based on the knowledge that the human body has a natural healing
ability, and that much can be done to enlist it in your care. Naturopathic doctors work with their
patients to use diet, exercise, lifestyle changes and leading-edge natural therapies to improve
their bodies’ ability to combat disease and decrease side effects of treatment. Naturopathic
services include:
• Nutrition
• Natural medicines (vitamins, minerals, botanicals)
• Acupuncture / Acupressure
• Risk reduction for cancer recurrence
• Re-establishing health
• Counseling
Nutrition Counseling
Nutrition counseling is provided for specific disease and symptoms to decrease the side
effects of treatment. Vitamins and supplements are also addressed.
Acupuncture
Of all the support services we offer, acupuncture is one of the most often requested. For
many of our patients and their referring oncologists, it plays a valuable role in addressing
cancer from every angle. Studies show that acupuncture can help relieve cancer’s
symptoms and the side effects of treatment, including nausea, vomiting, fatigue and
stress.
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We make the best acupuncture available to you through our collaboration with Bastyr
University, a national leader in natural health arts and sciences education and research. If
you’re interested in making acupuncture part of your personal treatment plan, please talk
with your doctor or nurse.
Mindy-Body Medicine
Mindy-Body medicine is a field of medicine that uses the powers of the mind to enhance
physical and emotional health. Patients learn to use the mind’s healing abilities to relieve
stress, manage symptoms, help with sleep, and restore mind, body, and spirit. Hypnosis,
biofeedback, and relaxation techniques are taught.
Wellness Consults
Wellness consults are provided through the naturopathic medicine provider. Learn what
steps to take after you are finished with treatment to return to wellness.
Language Support
For patients and their families who speak little or no English, we offer a toll-free telephone
interpreter service. We invite patients to use this service to make appointments and related phone
calls. Family members may use the service to call a loved one who is a patient in the hospital.
Palliative Care
Palliative care is dedicated to managing disease and treatment-related symptoms that help
preserve quality of life for patients during all stages of serious illness. Our Palliative Care team
includes nursing support through Partners in Palliative Care, together with medical care from our
Palliative Care physician and Advance Registered Nurse Practitioner. These clinicians work
together with your oncologist and the Patient Support Services Team to provide comprehensive
care for the physical, emotional and spiritual needs of you and your family—always with your
permission and your input. Palliative care is here to help in many ways, including:
• Managing pain and other symptoms
• Improving communication with your health care team, if needed
• Identifying goals of care
• Providing information about Advanced Directives
• Addressing home care needs
• Maintaining quality of life
Spiritual Care
Spirituality means different things to each of us—but for many people, it’s an essential part of
getting through a difficult time in life.
The chaplains at the adjacent Providence Regional Medical Center are available to help you
through any emotional or spiritual aspects of your treatment. Professionally trained and boardcertified, they are great listeners who do everything possible to support you and your family
regardless of your religious beliefs. We strongly believe in respecting the cultural and spiritual
diversity of those we serve.
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Support Groups
Studies show what cancer patients know from their own personal experience: A support group
can often play a valuable role in helping you feel better and get better. A good support group can
be a powerful source of information, help, encouragement and understanding throughout your
cancer treatment—for you and your loved ones. We offer a number of free, ongoing support
groups here.
Retrieved from http://www.cancerpartnership.org/Support-Resources.aspx
(PRCP, n.d.)
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Art Therapy Group
Art therapy increases your awareness of yourself and others and is a great therapeutic tool for
cancer patients. It is fun and life-affirming, and enhances cognitive abilities. This class offers a
supportive, non-judgmental environment, and no artistic ability is required. Our art therapists,
trained in both art and therapy, offer guidance and support, as well the opportunity to explore a
variety of art materials.
Women with Cancer Support Group
Previously the Breast Cancer Support Group
A support group for women who have or have had cancer. Connect with other women to
maintain a positive focus and self-image and to build a support network. Topics include coping
and relaxation strategies, breast cancer education, adjusting to change and guest speakers on a
variety of topics.
Breast Cancer Support Group
For breast cancer patients and survivors to connect with each other and to maintain a
positive focus and self-image, building a support network, and learn coping and
relaxation strategies.
Young Breast Cancer Support Group
A support group for women who have or have had breast cancer. This group is target at women
who are in their 20’s, 20’s, and 40’s. Facilitated by an Oncology Social Worker.
Gentle Yoga
Reconnect with your body and learn how to be gentle with yourself in a fun, noncompetitive
environment. This non-aerobic form of exercise concentrates on movements and deep breathing.
It can help reduce stress and fatigue, as well as improve sleep. Exercise promotes healing and
well-being during cancer treatment and can help accelerate your long-term recovery process.
Facilitated by oncology yoga instructors. First five sessions are free.
Look Good… Feel Better
Sponsored by the American Cancer Society, this class is designed for women going through the
effects of cancer treatment. The class focuses on skin and hair care, cosmetics, wigs and head
wraps, dealing with hair loss, and getting healthy nutrition. Cosmetic samples and makeovers are
available. All cosmetic products for your makeover are complimentary and provided for you to
enjoy and take home with you. Registration required.
Nutrition Class
Learn about the foods that can strengthen your immune system, improve your energy, and
maintain a healthy weight. Our free nutrition class is dedicated to helping patients, survivors,
family members and other caregivers improve their health through better eating. Facilitated by a
registered dietician.
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Man-to Man Prostate Cancer Support Group
This group offers education and information sharing exclusively for men who have been
diagnosed with, or who have had, prostate cancer. Facilitated by a cancer survivor contracted by
Providence Regional Medical Center.
Support Group for Cancer Patients and Survivors
Combines two previous support groups: Caregiver Support Group and Support Group for
Patients with Metastatic Disease
This support group is open to all cancer patients and survivors who have been diagnosed with
any type of cancer. Members offer each other comfort, support, information, and suggestions for
coping with potential challenges during and after treatment. Discussions may include developing
a resiliency plan, work issues, designing a holistic health plan, finding hope and meaning,
adjusting to effects of treatment, and building a support network.
Caregiver Support Group
This group teaches caregivers how to support someone with cancer while still taking care
of themselves. Make time for yourself, maintain a positive focus, build a support network,
learn coping and relaxation strategies, and more.
Support Group for Patients with Metastatic Disease (Advanced Cancer)
This group focuses on living with cancer and what it means to have metastatic disease.
The discussion includes topics such addressing pain and other symptoms, increasing
quality of life, managing treatment’s late effects, talking to your family, getting the help
you need, and interpreting medical information.
Tai Chi Self-Cultivation
Re-experience your mind and body through the practice of relaxing meditative movements.
Participants will also receive information and learn how to promote self-care through positive
psychology.
Survivorship Series Program
This eight-week services will give you ideas on maximizing your resources and strengths to help
you adjust to life after treatment. As part of your own health care team, you will be given the
opportunity to identify a wellness plan that is best for you. Registration required.
(PRCP, 2015b)
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PURPOSE
To comply with Standard 3.2, American College of Surgeons, Commission on Cancer. The
importance of screening patients for distress and psychosocial health is a critical step in
providing high-quality cancer care. The purpose of this policy is to assure that distress is
recognized, monitored, documented and treated promptly at all stages of the disease. A standard
process is in place to incorporate distress screening into the standard of care for oncology
patients and provide patients identified with distress with appropriate resources or referrals.
The Medical Director of Psychosocial Services oversees this activity and reports to the cancer
committee annually.
PROCESS
Timing of Screening and Method
All patients diagnosed with cancer who seek treatment at PRCP are screened for distress a
minimum of one time per treatment episode, although multiple screenings are scheduled for each
patient. Due to the differential nature of radiation and chemotherapy treatment protocols, a
distress screening protocol was developed for each. A standard patient questionnaire is used with
all patients. If a patient is unable to read or use the paper form for any reason, clinical staff will
verbally administer the screening.
Radiation Oncology patients receive the distress assessment the day of their intake appointment
with the nurse. This is completed with the nurse intake. The front desk receptionist gives the
form to the nurse who reviews it and incorporates it into the nurse intake. The nurse then initials
the distress assessment and puts it in the patient support box at the front desk. Patient Support
staff review the distress assessment forms daily, take necessary action, then take the forms to
medial records to be scanned into the patient’s chart.
Medical Oncology patients receive a distress assessment each time they are scheduled for both
an office visit with a provider (MD, ARNP, or PA) and infusion treatment. The front desk
receptionist gives the form to the patient to fill out in the reception area. The patient gives the
completed distress assessment form to the medical assistant who documents the level of distress
in the medial record and leaves the completed form for the provider to incorporate into their
visit. The form is then put into the patient support box at the nursing station. Patient Support staff
review the distress assessment forms daily, take action, then take the forms to be scanned into the
patient’s chart.
Tools
A distress measure was developed based on the NCCN Screening Tool for Measuring Distress.
Patients who meet the following criteria using this measure receive further evaluation for followup care:
• Distress rated at or above 5 on a 1–10 scale (unless the box marked “No follow-up is
needed at this time” is checked)
• Emotional, spiritual, family, or other concerns checked (unless the box marked “No
follow-up is needed at this time” is checked)
• Any level of distress if the patient checks the box stating “I wish to be contacted
regarding my concerns”
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Assessment and Referral
If there is evidence of moderate or severe distress, as determined by the distress assessment
questionnaire or by a member of the oncology team, further assessment will be done by a
member of the Patient Support team within 72 hours. Assessment is done to determine if there
are any psychological, behavioral, social, practical, financial, or spiritual problems that might
interfere with the patient’s ability to participate fully in their healthcare and adequately manage
their illness.
Distress assessment questionnaires are collected each day and patients identified as needing
follow-up are contacted either in person or by phone. In some instances patients are not
contacted directly but are mailed information if they identify low levels of distress but indicate a
desire for more information about specific supportive services such as available classes or
support groups.
If the patient is in severe distress and needs to see someone immediately, any staff member may
call the patient support pager. A patient support staff member will respond and assess the need
for service.
Documentation
Distress screening and follow-up is documented in the patient’s medical record. The distress
assessment form is scanned into the record. All contact with patients, whether in person or by
phone, are documented as clinical notes.
COMPLIANCE
A quality measure has been established to assure that patients are screened for distress. Each
month a sample of at least 30 new treatment patients are identified. Each patient’s medical record
is reviewed for documentation of a distress screening within 30 days of the start of a treatment
episode. The standard is that 95% of new treatment patients will have a documented distress
screening within 30 days.
(PRCP, 2012b)
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Please circle the number that best describes how much distress you have been
experiencing in the past week including today.
No
Distress

Extreme
Distress
0

1

2

3

4

5

6

7

8

9

10

I wish to be contacted regarding my concerns
No follow up needed at this time

Practical Concerns
Insurance
Unable to pay bills
Legal (POA, living wills, etc)
School/Work
Transportation
Housing
Child care
Chores
Bathing/dressing
Sleep
Respite care
Family Problems
Dealing with children
Dealing with partner
Intimacy/Sexuality
Spirituality
Spiritual support
Questions of faith

Emotional Problems
Depression
Fears/Worry
Nervousness
Sadness
Loss of interest in usual
activities
Other problems or concerns

I would like information about:
Social Security benefits
Medicaid benefits
Medicare benefits
Nutrition
Exercise & movement
Hospice
Support groups
Other
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Multidisciplinary Cancer Committee (MDCC)
Chair: Elie Saikaly, MD
Meets quarterly and is charged with ensuring compliance with ACoS standards for all the Cancer
Programs.
Multidisciplinary Cancer Committee Quality Assurance (MDCC QA)
Chair: Elie Saikaly, MD
Meets quarterly and is charged with ensuring, tracking, and reporting of all quality assurance and
improvement activities for all the Cancer Programs.
Cancer Executive Committee
Chair: Elie Saikaly, MD
Meets monthly as the strategic and business development forum for the Cancer Program.
Integrative Medicine Committee
Chair: Cheryl Beighle, MD
Meets quarterly to educate and develop programs for patients.
Lung Task Force
Chair: Kimberly Costas, MD
Meets monthly to identify and implement multidisciplinary best practices for lung cancer
patients to reduce time from diagnosis to treatment.
Medical Directors Meeting
Chair: Elie Saikaly, MD
Meets quarterly to oversee the operational management of the Cancer Partnership.
Psychosocial Committee
Chair: Kathryn Johnson, PhD
Meets quarterly to plan and implement program and service development to meet cancer
patients’ psychosocial needs.
Survivorship Steering Committee
Chair: Dawn Dickson, MSW, LICSW
Meets quarterly to plan and implement a Survivorship Program offered at Providence Regional
Cancer Partnership
(PRCP Annual Report, 2012a)
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Proposed Program Evaluation of Patient Support Services Stakeholder Brainstorming Meeting
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The following summary information was generated during an initial brainstorming meeting with
identified stakeholders during PRCP’s fall quarterly Psychosocial Steering Committee meeting.
ATTENDEES
Kathryn Johnson, PhD, Julie MacDougall, Kelly Mardesich, RN, Kathy Reiff, Elie Saikaly, MD,
Margaret Salmassy, Gerald Vasquez, Justine Colombo, MSW, Mary Jo Sarver, RN, Carrie
Pilger, and Kristoffer Rouse
PRCP VISION
“A comprehensive, regional, state-of-the-art, single destination designed exclusively for the
cancer patient and family with integrated and seamless clinical, operational and business
processes.”
PROGRAM EVALUATION
Definition
Program Evaluation addresses professional issues through the use of evaluation design, problem
formation, methodology, analysis of relevant quantitative and/or qualitative data, and report of
findings in a constructive fashion. It may include questions pertaining to program utilization,
implementation, fine-tuning, and effectiveness.
Purpose
To judge the merit or worth of a program and provide information for program improvement.
Audience is generally people delivering the program or people who are in a position to make
changes in the program and its day-to-day operations. Questions typically asked: What is
working? What needs to be improved? How can it be improved?
BRAINSTORMING PHASE
What aspects of the program should be evaluated? From a patient perspective, what should be
evaluated?
• Elie: What is the purpose and value of PSS? Can a new intervention be added to PSS?
• Justine: What is the current patient experience? How do program services affect staff
members? What is the cost and/or time savings on providers and the institution as a result
of PSS?
• Mary Jo: What is the utilization of services among different types of cancer?
• Margaret: How does PRCP compare to other Providence cancer programs?
• Kathryn: How effective is the model of care based on current staffing? How does our
model of care compare to other cancer programs? What is the difference between people
who receive program services and those who do not? Is our mission still accurate? Are
we doing what we said we would and are we doing it well?
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Input
• If you have
access to
certain
resources,
then you
can use
them to
accomplish
your
planned
activities

Output
• If you
accomplish
your
planned
activities,
then you
can deliver
the product
or service
you intend

Outcome
• If you
accopmlish
your
planned
activites,
then your
participants
will benefit
in specific
ways

Impact
• If benefits to
partipants are
achieved,
then changes
in systems
might occur

Note. From “Logic Model Development Guide” by W. K. Kellogg Foundation, 2004b, p. 3.
Reprinted with permission.
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Outcomes Approach Logic Model
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Program Rationale: Persons affected by cancer experience psychosocial distress

Input

Output

Outcomes

Outcomes

Patient Support
Services
• Individual,
couples, & family
counseling
• Support groups
• Crisis intervention
& safety
assessment
• Formal/informal
assessment
• Psychoeducation
• Consultation
• Community
resourcing &
outside referrals

• Number (#) of
patients served
annually
• Number (#) of
annual ER visits
• Utilization (%) of
PSS services
• Distress
Assessment
questionnaires
• Satisfaction
interviews

Short-term (1-3
years)
• Manage & triage
psychosocial
distress
• Decrease annual
ER visits
• Increase treatment
compliance
• Increase staff and
patient satisfaction

Long-term (4-6
years)
• Increase cost &
time savings
• Increase
department
referrals

Planned Work

Impact
(7-10 years)
• Increase annual
number (#) of
patients served
• Increase program
services &
utilization of
services
• Increase funding
opportunities

Intended Results

Note. Adopted from W. K. Kellogg Foundation (2004b, p. 54).
Input/Activities: Describes the activities conducted in the program. May include
products, services, and infrastructure.
Outputs: Refers to the direct results produced by a program activity. Usually quantified
in terms of size and/or scope of the services delivered or products produced.
Outcomes: Refers to short-term and long-term outcomes expected as a result of each
activity implemented. May include individual changes in attitude, behavior, knowledge,
skills, status, or level of functioning.
Impacts: Refers to the results expected 7–10 years after an activity has been
implemented. Reflects the impact activities and subsequent results have on an
organizational, community, or systems level. May include improved program conditions,
expanded services, or changes in policy and procedures. (W. K. Kellogg Foundation,
2004b, p. 8)
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We are interested in your feedback about our services. Please take a moment to complete this
survey and return it to any reception desk or suggestion box. Thank you!
o
o

Are you a patient receiving treatment or a friend/family member?

Patient
Friend or family

Have you heard about the services available through the Patient Support Services Department?
(counseling, social work, nutrition, support groups, etc.) Please check one:
o I am well informed
o I have some limited knowledge and know where to go if I need to
o I could use more information
o I have never heard about Patient Support
Gender:

o

Male o

Age:

o
o

18–25
45–54

o
o

26–34
55–64

Marital Status: o
o

Single
Separated

o

o Married or Domestic Partner
Divorced
o Widowed

Race/Ethnicity: o
o
o

Caucasian/White
o
African American/Black
o
American Indian/Alaska Native o

Female
o
o

35–44
65–74

o

75+

Hispanic/Latino
Asian/Pacific Islander
Other _______________

What year did you start treatment at Providence Regional Cancer Partnership? _______
What type of cancer is being treated? Please select all that apply:
o Aids-related Cancer
o Bladder Cancer
o Bone Cancer
o Brain Tumor
o Breast Cancer
o Cervical Cancer
o Colorectal Cancer
o Endometrial Cancer
o Esophageal Cancer
o Gallbladder Cancer
o Gastrointestinal Tumor
Stage of cancer: o 0

oI

o Gestational
Trophoblastic Cancer
o Head and Neck Cancer
o Hodgkin's Lymphoma
o Kidney Cancer
o Leukemia
o Liver Cancer
o Lung Cancer
o Malignant Mesothelioma
o Melanoma
o Multiple Myeloma
o II

o III

o IV

o Non-Hodgkin's
Lymphoma
o Ovarian Cancer
o Pancreatic Cancer
o Prostate Cancer
o Skin Cancer
o Soft Tissue Sarcoma
o Uterine Cancer
o Other: ______________
______________________

o Unknown o N/A
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What treatment(s) have been received during the past 12 months? Select all that apply:
o Biopsy
o Palliative Care
o Hormone Treatment
o Hospice
o Radiation
o Clinical Research Trial
o Surgery
o Calmare Pain Therapy Treatment
o Chemotherapy
o Observation Only
o Other
Have you used Patient Support Services at any point during treatment at Providence
Regional Cancer Partnership? Please check one: oYes o No
If so, which services have you used? Please check all that apply:
o emotional support during treatment (infusion, radiation, hospitalization)
o counseling with a PSS staff member (psychologist, social worker, intern)
o attending a support group: which group(s)?
o social work, resources, or financial assistance
o other
How likely are you to use or continue using Patient Support Services during your
treatment at Providence Regional Cancer Partnership?
oVery Likely oSomewhat Likely oMaybe oSomewhat Unlikely oVery Unlikely
How satisfied have you been with the quality of services provided by Patient Support?
o Satisfied
oSomewhat Satisfied oNeutral oSomewhat Dissatisfied oDissatisfied
How satisfied have you been the variety of services provided by Patient Support?
o Satisfied
oSomewhat Satisfied oNeutral oSomewhat Dissatisfied oDissatisfied
How satisfied have you been with Patient Support Services staff access and responsiveness?
o Satisfied
oSomewhat Satisfied oNeutral oSomewhat Dissatisfied oDissatisfied
Do you consider Patient Support Services a valuable part of your cancer treatment at
Providence Regional Cancer Partnership?
oStrongly Agree oAgree
oNeutral
oDisagree
oStrongly Disagree
How likely are you to recommend Patient Support Services to other patients or family
members?
oVery Likely oSomewhat Likely oMaybe oSomewhat Unlikely oVery Unlikely
In your experience, which Patient Support Services have been most helpful?
Please select one:
o Emotional support provided in the office or during treatment
o Support group opportunities
o Access to resources and financial support
o Other: ______________________
What else could Patient Support Services do to improve services?
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Number of years employed at PRCP:

□< 1

□1–2

Position: □MD

□Other Clinical Staff

□3–4

□ 5–6

□ 8–9

□ACP
□RN
□MA
□ Support Staff □ Administration

1. How familiar are you with the services offered by Patient Support?

□
5

□

□

□

□

4

3
Somewhat

2

1
Not At All

Very

2. How often do you refer patients or family members to Patient Support Services?

□
5
Very Often

□
4

□
3
Sometimes

□
2

□
1
Not At All

3. In what types of situations do you typically refer patients to PSS? Please select all that apply:

□ Not applicable: I don’t refer patients in my position
□ When a patient appears upset or distraught
□ When a patient receives upsetting news
□ When a family member has concerns or needs support
□ When a patient has difficulty understanding diagnosis, prognosis, or treatment options
□ When a patient appears cognitively impaired or has difficulty comprehending
information

□ When a patient’s health begins to decline
□ When a patient has complex medical and/or psychosocial needs
□ When a patient appears at risk of self-harm or injury (i.e., intoxication, suicidality,
domestic violence, vulnerable adult abuse)

□ When a patient has upset staff or other patients
□ When a patient has financial concerns
□ When a patient has transportation concerns
□ When a patient would benefit from a nutrition consultation
□ When a patient would benefit from additional time or attention from staff
□ Other: ___________________________________________
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4. What PSS resources do you usually recommend to patients? Please select all that apply:

□ Financial/resources
□ Counseling
□ Cognitive testing
□ Nutrition
□ Other: ____________________

□ Support groups
□ Social Work
□ Cancer Resource Center
□ Not applicable

5. Do you consider Patient Support Services a valuable part of PRCP’s cancer treatment
program?

□

□

5
Very Much

4

□

□

3
Somewhat

□

2

1
Not Really

6. Do you think Patient Support Services positively affects treatment outcomes for patients?

□
5
Very Much

□

□

□

□

4

3
Somewhat

2

1
Not Really

7. Research suggests several benefits when psychosocial services are offered along side cancer
treatment. In your opinion, what outcomes might be likely to happen, in part because a
patient has participated in Patient Support Services? Please select all that apply:

□ Reduced risk of developing more severe emotional distress or disorders
□ Improved ability to cope with expected distress throughout cancer treatment
□ Improved overall health and level of functioning
□ Improved satisfaction with the services available for cancer care
□ Increased treatment compliance and follow up care
□ Reduced workload for treatment providers or support staff
□ Lower use of unnecessary medical or emergency services
□ Reduced financial costs of our larger medical system
8. What do you think the Patient Support Services team does particularly well? Please select all
that apply:

□ Assesses psychosocial needs
□ Facilitates support groups
□ Provides emotional support to patients and family members
□ Provides crisis intervention or urgent risk assessment
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□ Helps manage or triage patients with high acuity or psychosocial distress
□ Other __________________________________
9. What can Patient Support Services do to improve its services? Please select all that apply:

□ Increase staff access during business hours
□ Improve staff response time for urgent needs
□ Offer support groups more frequently
□ Offer more support service options
□ Generate revenue or funding opportunities for the cancer center
□ Offer publicity or marketing within our community to recruit patients
□ Nothing! Keep doing what you’re doing!
□ I’m not sure
□ Other: ______________________________________________
If you would be willing to be contacted for a brief, informal interview to say more about your
experience utilizing Patient Support Services, please provide your name for follow up:
____________________________________________________________________________
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EXECUTIVE SUMMARY
PROGRAM EVALUATION OF PSYCHOSOCIAL SUPPORT SERVICES AT PROVIDENCE
REGIONAL CANCER PARTNERSHIP- MAY 2016
NICOLA B. MUCCI, MA, LMHC

EVALUATION PURPOSE AND EVALUATION QUESTIONS
The purpose of this program evaluation was to better understand (a) how patients utilize Patient Support
Services and (b) what patients and staff value about program services. This evaluation sought to provide
an overview of program services as they are currently utilized and to offer informed program
recommendations based on identified areas of satisfaction and dissatisfaction.

EVALUATION DESIGN AND METHODS
UTILIZATION OF SERVICES
• EHR audits: 300 single-use and multiuse participants; 100 group users
• Inclusion criteria: PSS participation July 2014–June 2015
• Data collected: Patient demographics (age, gender, insurance), diagnostic information (cancer
origin, stage), treatment modalities (surgery, chemotherapy, radiation), PSS services (CRC, NT,
FA, OV, INF, SG, family services)
• Utilization of services was compared among four sets of data: 1) all new cancer cases at PRCP, 2)
single-use participants, 3) multiuse participants, and 4) group participants
SATISFACTION OF SERVICES
• STAFF SURVEY: Survey Monkey, forced-choice Likert scale
o Inclusion criteria: Direct/indirect patient interaction
o Response rate: 41 of 110 staff invited (37%)
• PATIENT SURVEY: Paper copies, forced-choice Likert scale
o Inclusion criteria: Patients available during INF or SG July–October 2015 (n = 150);
mailed to patients who attended new patient OV July–October 2014 (n = 440)
o Response rate: 152 of 590 surveys distributed (26%)

EVALUATION FINDINGS
PROGRAM STRENGTHS
UTILIZATION OF SERVICES
In general, utilization of services data appears to align with the mission of PSS
• While this evaluation is not an exhaustive analysis of utilization of services, it did demonstrate
that more than 17.3% of all new patients at PRCP interacted with PSS beyond DA; services
provided by one 0.8 MSW, 2 FT interns
• Participation in program services was highly reflective of patients’ needs and presumed financial
resources. Medicaid patients were more likely to participate in nearly all program services,
despite comprising only 16% of participants and 7.5% of all new cancer cases. Medicare patients
were more likely to request follow up on DAs, while commercial users were twice as likely to
participate in SGs
• Advanced cancer patients used services more frequently and diversely. Stage IV patients
represented 19.7% of all new cancer cases at PRCP, but represented 53% of multiuse participants
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PATIENT PERSPECTIVE
• Eighty-two percent of patients are informed of program services
• Greatest program strength is emotional support
• High satisfaction of quality and variety of program services
• High satisfaction of staff access and responsiveness
• Psychosocial services perceived as having high value as part of cancer treatment
• Likelihood of using services or referring others to program services highly dependent upon prior
use of services
STAFF PERSPECTIVE
• Sixty-eight percent of staff report familiarity of program services
• Highly regarded as being valuable and having positive effects on patient outcomes
• All program services recommended with high consistency
• Greatest program strength is emotional support
• Most perceived benefits of PSS: Increased ability to cope with distress, reduction in severe
emotional disorders, higher satisfaction with cancer care treatment, increased treatment
compliance, and increased overall health and functioning

PROGRAM LIMITATIONS AND RECOMMENDATIONS
Proposed recommendations are offered with input form PSS staff and other stakeholders
UTILIZATION OF SERVICES
• Women comprised 56% of all new cancer cases, but represented 68% of all program participants
• Breast cancer patients were superiorly overrepresented among all program participants and across
all program services. Despite high national prevalence rates, male reproductive cancer patients
were underrepresented across all new cancer cases as well as program services
PROPOSED RECOMMENDATIONS
• Diversity of services (gender): Market program services for men with cancer: Men
represent 44% of all new cancer cases, but only 32% of program participants (15% group users
and 36% of multiuse participants)
• Diversity of services (cancer): Based on projected prevalence rates of common cancer
diagnoses reported by NCI, focus recruiting a more diverse group of patients to participate in
program services
o Program services should aim to target commonly diagnosed cancers that are similarly
represented among all new cancer cases at PRCP. According to the NCI, the most
commonly diagnosed cancers include bladder, breast, colorectal, endometrial, kidney,
leukemia, lung, melanoma, non-Hodgkin lymphoma, pancreatic, prostate, and thyroid
cancer
• Support groups: While SGs tend to be a well known aspect of cancer support services and
have the potential to reach a large and diverse group of people, it is worth further evaluating how
SGs are currently utilized at PRCP
o Evaluate use of staff resources compared to attendance numbers, diversity of participants,
and the ability to reach a large and broad audience
o Evaluate how many SGs are needed to meet the emotional needs of patients and
caregivers. Can current SGs be consolidated to reach a higher volume of patients (i.e., all
men or all women with cancer) vs specialized SGs (i.e., women with breast cancer)?
What is the advantage of offering open vs. closed groups that require registration or are
held for a limited time (i.e., eight weeks) vs. ongoing?
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o

Evaluate what attracts the most attendees to SGs. For example, should funds be allocated
to inviting guest speakers?

EDUCATION AND OUTREACH
IDENTIFIED CONCERNS
• Staff education and encouragement to use services; limited emphasis on “integrative services”
• Patient education and outreach
• Advertisement of program services
PROPOSED RECOMMENDATIONS
• Staff education: Only 37% of staff refer to PSS “often” and 39% refer “sometimes”
o Create a quarterly PSS newsletter that includes staff biographies and specialties, patient
narratives describing frequent scenarios or illustrating program resources and utilization
of services. Distribute the newsletter via email and place hard copies in the staff lounge
o Have a PSS representative attend quarterly all staff service meetings; have a PSS
representative attend PRCP cancer conferences
o During NEO job training, have new staff shadow a PSS staff member
• Patient education and outreach: Once a month, set up a “meet and greet” table in INF to
distribute program information, answer questions, and increase staff visibility
o Consider placing a support staff person in the first floor reception area to help direct
patients and increase visibility of first floor services
• Marketing and advertising: Advertise PSS services in prominent locations such as INF
and nursing stations; create quick fact sheets with PSS contact information, program services, and
commonly requested resources (i.e., COPES, SSDI, transportation)
o Consider investing in television monitors that can be mounted in common areas such as
the waiting room. Screensavers can advertise program services, PSS biographies and
contact information along with other PRCP information. Update the phone message to
advertise PSS services while callers are on hold
o Monitor the accuracy of current marketing materials and update information frequently
(i.e., printed brochures, website information)
SERVICES AND ACCESS
IDENTIFIED CONCERNS
• Transportation services
• Transitioning onto hospice care
• Support for family members and caregivers (endorsed by patients + staff)
PROPOSED RECOMMENDATIONS
• Transportation: Provide handouts that advertise available transportation services and
eligibility. Evaluate whether dissatisfaction reflects problems with transportation services and
eligibility, or a deficit in how PRCP uses services.
o Consider allocating PAF towards alternate transportation options (i.e., ferry tickets, bus
fare) and additional gas cards
• Hospice care: Evaluate how and when referrals are made to hospice to better understand
concerns and areas for improvement
• Family services: There is already a high inclusion of family involvement in services occurring
naturally (17% single-use, 42% multiuse, 37% group). Market services for family members and
caregivers more explicitly; create a brochure that markets services toward caregivers and include
a list of outside resources available for caregivers
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STAFFING
IDENTIFIED CONCERNS
• Training and education of PSS staff; inconsistency providing care (patient criticism)
• Staffing access—availability, visibility, and lack of full-time staffing (staff criticism)
• Response time on urgent needs—difficulty reaching staff and less than desirable response time on
calls, pages, and DAs; ability to triage patients with high acuity ranked low as a department
strength
PROPOSED RECOMMENDATIONS
• Staff training and consistency: Create a standard training program with learning modules
on department needs for interns. Create procedural flow charts that illustrate level of patient care,
available resources, and program services (i.e., COPES, SSDI, PAF)
• Staff access: Create one centralized phone number to contact all PSS staff
o FT staffing: Evaluate the ratio of full-time PSS staff to patients compared to other cancer
treatment programs to determine if PRCP staffing is similar and/or sufficient
o Evaluate the sustainability of the internship program. What is the long-term sustainability
of PSS services based on current staffing conditions?
o Visibility concerns may also be addressed via improvements made to staff education,
patient outreach, and program marketing (as indicated above)
• Response time: Evaluate QA measures to assess timely follow up on urgent referrals and DA
response time

ACRONYMS & ABBREVIATIONS
COPES
CRC
DA
EHR
FA
INF
MSW
NCI
NEO
NT
OV
PAF
PSS
QA
SG
SSDI

Community Options Program Entry System (WA Medicaid program)
Cancer Resource Center
Distress Assessment
Electronic health record
Financial support (i.e., Patient Assistance Fund, SSDI applications)
Infusion
Master of social work
National Cancer Institute
New Employee Orientation
Nutrition
Office visit
Patient Assistance Fund
Patient Support Services
Quality assurance
Support group
Social Security Disability Insurance program
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National Academies Press hereby granted permission at no charge for the following materials to
be reused in the present dissertation manuscript.
• Figure 1. Model for the delivery of psychosocial health services
• Table 1. Psychosocial needs and formal services to address them
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Providence Regional Cancer Partnership hereby granted permission at no charge for the
following material to be reused in the present dissertation manuscript.
• Appendix K: Distress Assessment tool
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W. K. Kellogg Foundation hereby granted permission at no charge for the following materials to
be reused in the present dissertation manuscript.
• Appendix N. Logic Model: If…Then Assumptions
• Appendix O. Outcomes Approach Logic Model
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